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Abstract
Background Information
The global misuse and overuse of antibiotics in human medicine and the animal production
industry is contributing to the development of antibiotic resistance in bacteria. This is a
serious threat to modern medicine and public health. Antibiotic resistant organisms can
cause severe infections in humans which are difficult to treat, and in some cases impossible
to resolve which can lead to premature death. Several studies have been conducted across
the globe to assess the use of antibiotics in the seafood industry and the associated health
risks, however, limited studies have recently explored this risk in an Australian setting.

Aims
This thesis aimed to investigate the presence of antibiotic residues in seafood sold in
Western Australia. Furthermore, the occurrence of antibiotic resistance in Gram negative
bacteria isolated from fish sold in Perth, Western Australia was assessed. The impact of
country of origin on the presence of antibiotic residues and antibiotic resistant bacteria in
seafood samples has also been considered.

Methodology
Historical data was accessed from the Local Health Authorities Analytical Committee
regarding the presence of eight antibiotic types in 253 seafood samples purchased
throughout Western Australia between May and June 2017.

Forty-four fish samples, a mix of local and imported from Asian countries, were sourced from
retail shops located in the metropolitan area of Perth between September and November
2017. Gram negative bacteria were isolated by homogenisation of the fish with a Luria
Bertani Broth and incubation on media selective for Gram negative bacteria. A series of
preliminary microbial identification tests were conducted on selected bacterial isolates.
Matrix Assisted Laser Desorption Ionization-Time of Flight confirmed the identification of the
bacteria to species level. The identified bacteria (n = 35) were analysed for antibiotic
susceptibility to eight antibiotic types using the standard disc diffusion method.

Results
The majority of seafood samples were free from antibiotic residue contamination and
compliant with Australian legislation. A single non-compliant sample contained antibiotic
residues below the level required to pose an immediate health risk to the consumer. This
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result suggests the Australian consumer has limited risk of consuming antibiotic residues in
seafood.
Thirty-five Gram negative bacterial isolates from ten genera were identified. The majority of
the antibiotic resistance observed in the bacteria was either explained by intrinsic resistance
or was similar to previous reports. Potential acquired antibiotic resistance was observed in
four Acinetobacter species and a Rhizobium isolate which were isolated from commonly
farmed fish from Australia (n = 1), China (n = 1) and Vietnam (n = 3). It is possible the fish
may have been exposed to antibiotics during the production cycle. However, this result must
be read with caution since there are limited standardised breakpoint guidelines for these
particular species and, therefore the results were inferred using guidelines for other, similar,
bacterial species.
From these results, it appears that there is limited risk to consumer health from exposure to
antibiotic resistant bacteria via consumption of seafood, however, only a limited number of
samples were assessed, and Gram positive bacteria were not evaluated in this study. These
results are reassuring but suggest that vigilance is required to ensure that the risk to
consumers is minimised. Where antibiotics are used inappropriately in environmental
settings, the risk of environmental bacteria developing further antibiotic resistance will
remain. Routine surveillance of antibiotic resistance in pathogenic bacteria in domestic and
imported food of animal origin is recommended to monitor this potential risk to human public
health.
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Glossary
Acceptable daily intake
The maximum amount of an agricultural or veterinary chemical that can remain in a
food product without causing a health risk to the consumer. It is generally provided in
milligrams (mg) of the chemical per kilogram (kg) of the consumers body weight
(Codex Alimentarius Commission, 2016).
Aminoglycosides
A class of antibiotic drugs which act by inhibiting protein synthesis to resolve bacterial
infection. These drugs are generally broad spectrum and active against Gram
negative bacteria (Galbraith, Bullock, & Manias, 2004). Examples of aminoglycosides
are streptomycin, gentamycin and kanamycin.
Antibiotic
An antimicrobial chemical which either kills or inhibits the growth of bacteria. This
action can resolve and treat bacterial infection in humans and animals (Australian
Pesticides and Veterinary Medicines Authority [APVMA], 2017).
Antibiotic Class
The grouping of antibiotics by their chemical properties and mechanism of action
against bacteria (Gualerzi, Brandi, Fabbretti, & Pon, 2013).
Antimicrobial
A broad term which describes an agent that halts or destroys the growth of a
microorganism (Henriksson et al., 2018). Antimicrobials are grouped by the
microorganism they work against. Antibiotics are antimicrobials which work against
bacteria. Another antimicrobial is antifungals which are active against fungal growth.
Antibiotic Resistance
Antibiotic resistance is when the antibacterial action of an antibiotic fails to kill or
inhibit bacterial growth. It is a natural evolutionary process that has been accelerated
by the overuse and misuse of antibiotics in human medicine and agriculture (Holmes
et al., 2016).
Antimicrobial Resistance
A broad term used to describe the circumstances when an antimicrobial agent no
longer works as intended to inhibit or destroy its target microorganism (Fletcher,
2015).
Aquaculture
Also known as fish farming, is the practice of raising, breeding and harvesting aquatic
organisms, generally for human consumption. Aquaculture occurs in fresh and salt
water. Interventions are applied to improve production, including the application of
feed and medicine (Sapkota et al., 2008). A variety of aquatic organisms can be
reared in aquaculture such as species of fish, molluscs and crustacean (Food and
Agriculture Organisation of the United Nations [FAO], 2016).
Beta-lactam (β-lactam)
The categorisation of antibiotic agents chemically related with a similar molecular
structure which contains a beta-lactam ring (Blair, Webber, Baylay, Ogbolu, &
Piddock, 2015). See Cephalosporins and Penicillin
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Cephalosporins
A class of semi-synthetic antibiotic drugs which are broad spectrum and active
against Gram negative bacteria, they work by blocking cell wall synthesis (National
Institutes of Health, 2017). There are five generations designed to increase
effectiveness to treat infection. Examples of cephalosporins include cefalotin and
cefalexin (first generation) and cefotaxime (third generation). Cephalosporins are also
categorised as beta-lactam antibiotics.
Critically Important Antimicrobials
Categorised by the WHO: an antimicrobial is critically important for use in human
medicine if it meets two sets of criteria. Firstly, it must be the only available drug to
treat severe infections. Secondly, it must be used to treat infection caused by either
bacteria that are transmitted to humans from non-human sources (animals, the
environment or food), or bacteria that can potentially acquire antimicrobial resistant
genes from non-human sources (WHO, 2017a). See Highly Important
Antimicrobials
Efflux Pumps
Are part of the bacterial cell and are responsible for transporting antibiotics out of the
cell, ensuring that the antibiotic does not work against the bacteria and thus, are one
method of acquiring antibiotic resistance (Blair et al., 2015).
Fluoroquinolones
A group of antibiotics which are derived from quinolones by modification to include
the addition of a fluorine atom (Gualerzi et al., 2013). They are the second generation
onwards of the quinolone class of antibiotics, including norfloxacin and ciprofloxacin.
See Quinolones
Highly Important Antimicrobials
Categorised by the WHO: antimicrobials are highly important for human medicine if
they meet one of two sets of criteria; the first criteria, the antimicrobial must be the
only available drug to treat severe bacterial infections and the second criteria, the
antimicrobial must be used to treat infection caused by bacteria that are transmitted
from non-human sources (animals, the environment or food), or from bacteria that
can potentially acquire antimicrobial resistant genes from non-human sources (WHO,
2017a). See Critically Important Antimicrobials
Horizontal Gene Transfer
The exchange of genetic information from one bacterial organism to another bacterial
organism. This process includes the transfer of antibiotic resistant genes between
different bacteria. The three mechanisms of genetic exchange are conjugation (direct
contact with other bacteria), transduction (bacteriophage mediated) and
transformation (Deoxyribonucleic acid [DNA] uptake from the environment) (Marti,
Variatza, & Balcazar, 2014).
Inhibition Zone
In disc diffusion testing, it is the area directly surrounding the paper antibiotic discs on
the surface of the agar which shows no bacterial growth. The zone diameter is
measured and compared to guidelines to determine the susceptibility of the bacteria
to the tested antibiotics (European Committee on Antimicrobial Susceptibility Testing
[EUCAST], 2017).
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Macrolides
A class of antibiotics which inhibit the growth of bacteria by affecting the function of
the ribosomal subunit conducting the process of protein synthesis (Galbraith et al.,
2004). An example is erythromycin.
Maximum Residue Limit
The highest level of an agricultural or veterinary chemical that is permitted to remain
in products for human consumption as prescribed by national legislation or
international guidelines (Codex Alimentarius Commission, 2016; Food Standards
Australia New Zealand [FSANZ], 2018a).
Multidrug resistance
The ability of a bacteria to resist the antibacterial action of two, or more,
antimicrobials from different antibiotic classes (Qiao, Ying, Singer, & Zhu, 2018).
Nitrofurans
A class of antibiotics which work by targeting bacterial DNA (APVMA, 2017).
Examples of nitrofurans include furazolidone, nitrofurantoin and nitrofurazone.
Pan-drug resistance
The ability of bacteria to resist the antibacterial action of antibiotics from all
available antibiotic classes (Carlet, 2014).
Penicillins
A class of antibiotics which act by inhibiting the synthesis of bacterial cell walls. They
are also categorised as beta-lactam antibiotics. The first generation was derived from
the Penicillium mould and the newer variations are semi-synthetic (Galbraith et al.,
2004). Examples of penicillins are ampicillin and amoxicillin.
Prophylactic (Antibiotic Use)
The misuse of antibiotics in agriculture as a preventative measure to reduce the
chance of animals developing a bacterial infection by treating non-diseased animals
(Economou & Gousia, 2015).
Quinolones
A class of antibiotics which are synthetic drugs that act against bacteria by interfering
with DNA synthesis (Gualerzi et al., 2013). An example is nalidixic acid.
Sulfonamides
A class of synthetic antibiotics which act against bacteria by interfering with folic acid
synthesis (APVMA, 2017). Examples include sulfadiazine, sulfamethazine and
sulfamethoxazole.
Tetracyclines
A class of antibiotics which act against a broad range of Gram negative and Gram
positive bacteria by inhibiting protein synthesis (Gualerzi et al., 2013). Examples
include tetracycline, oxytetracycline and doxycycline.
Withdrawal Period
In veterinary medicine, it is defined as the time required between the last dose of
medication an animal receives and slaughter, to ensure that no traces of the
medicine remain detectable in the animal’s tissue (Okocha, Olatoye, & Adedeji,
2018).
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1.0 Introduction
Antibiotics are antimicrobial chemicals that kill bacteria or inhibit bacterial growth and are
therefore important drugs used in human healthcare to resolve infection (Done, Venkatesan,
& Halden, 2015). Global overuse and misuse of antibiotics is increasing in human medicine
and animal husbandry industries (Done et al., 2015; Laxminarayan et al., 2013). In certain
countries the use of antibiotics in the food animal industry exceeds the amount used in
human medicine, for example in China it is estimated that out of the total amount of
antibiotics used, 52% are used on animals (Aitken, Dilworth, Heil, & Nailor, 2016; Qiao et al.,
2018). Antibiotics are routinely used in cattle, swine, poultry and aquatic animal farms to
resolve illness, and to promote growth and prevent disease (Economou & Gousia, 2015). A
number of antibiotics used in agriculture and aquaculture are also deemed as critically
important or highly important for human medicine by the WHO, including the antibiotic
classes of sulfonamides, tetracyclines, quinolones and penicillins (Done et al., 2015).

Antibiotic resistance is a naturally occurring evolutionary process (Blair et al., 2015).
Selective pressure created by the excessive and inappropriate use of antibiotics in hospital,
community, agriculture and industrial settings has accelerated the prevalence of antibiotic
resistant bacteria (Angulo, Nargund, & Chiller, 2004; Xiong et al., 2015). The term
‘antimicrobial resistance’ is often used interchangeably with antibiotic resistance and also
applies to eukaryotic organisms such as yeasts and protists (Fletcher, 2015).

The WHO considers the spread of antibiotic resistance as one of the most significant threats
to modern public health (Deng, Li, Zheng & Lin, 2016). Globalisation creates opportunities
for antibiotic resistance to spread around the globe, putting all nations at risk (Barlam &
Gupta, 2015). Resistance to all antibiotic classes has been observed in a wide range of
bacteria, including those pathogenic to humans (Laxminarayan et al., 2013; Stein, 2011). Of
particular concern is the emergence and spread of multidrug resistant bacteria which have
acquired resistance to more than one antibiotic, and pan-drug resistant bacteria that
demonstrate resistance to all available antibiotics (Capita & Alonso-Calleja, 2013). Antibiotic
resistant infections are complicated to treat, and they often cannot be resolved, contributing
to increased morbidity and mortality rates (Economou & Gousia, 2015).

This study focusses on the use of antibiotics in the seafood industry and the associated
public health consequences, from an Australian perspective.
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2.0 Literature Review

2.1 Antibiotic Resistance
2.1.1 Mechanisms of Antibiotic Resistance
Bacteria acquire antibiotic resistance by spontaneous deoxyribonucleic acid (DNA) mutation
or horizontal gene transfer in which mobile genetic elements are exchanged through three
main mechanisms, transformation, conjugation and transduction (Berendonk et al., 2015).
Transformation involves the uptake of foreign DNA from the environment (Marti et al., 2014).
Conjugation is the transfer of plasmids or transposons between bacteria in direct contact
with each other by the formation of a sex pilus (Holmes et al., 2016). In transduction,
bacteriophages (viruses that infect bacteria) facilitate the transfer of DNA from one bacteria
to another (Sapkota et al., 2008). Horizontal gene transfer can occur between different
bacterial genera as well as within a single bacterial species (Fletcher, 2015). Increased
efficiency for horizontal gene transfer between related bacterial genera has been observed
(Elbashir et al., 2018).

Intrinsic resistance to specific antibiotics is present in many bacteria. This type of resistance
is inherent, influenced by characteristics of the microorganisms such as their physiology and
biochemical activity and is therefore unrelated to antibiotic exposure (Vaz-Moreira, Nunes, &
Manaia, 2014). This innate ability can occur through the activity of efflux pumps, absence of
drug target sites or poor permeability of the target cell wall (Capita & Alonso-Calleja, 2013).
For example, Vancomycin is a glycopeptide antibiotic which is not able to penetrate the outer
membrane of Gram negative bacteria due to its vast size, rendering the drug useless against
infections caused by Gram negative bacteria (Blair et al., 2015).

2.1.2 Health and Economic Impacts of Antibiotic Resistance
Many bacteria responsible for common infections are steadily developing antibiotic
resistance (Fletcher, 2015). In the United States of America (USA) alone, two million
illnesses are caused by antibiotic resistant bacteria each year (Aitken et al., 2016). Antibiotic
effectiveness is imperative to treat infections, and to prevent infection in those who have
undergone important medical treatments or procedures such as invasive surgery (Blair et al.,
2015). Antibiotic resistant infections are challenging and expensive to resolve, leading to an
increased burden on public health systems caused by prolonged disease duration and
disease complication (Economou & Gousia, 2015). Further, multi and pan-drug resistant
bacteria cause severe disease which is significantly harder to cure since there are fewer or
no available treatment options (Laxminarayan et al., 2013). Antibiotic resistant infections are
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often associated with premature death, contributing to increased mortality rates
(Laxminarayan et al., 2013). It is estimated there are 700,000 deaths annually from
antimicrobial resistance across the world (Watts, Schreier, Lanska, & Hale, 2017). It is
projected, based on current trends, that there will be 10 million deaths globally each year
attributed to antimicrobial resistance by 2050 (Watts et al., 2017).

The economic consequences of antibiotic resistance are dire. The health care system is
burdened by the increased cost associated with additional medical tests, longer hospitals
stays, infection control measures and expensive alternative treatment options (Economou &
Gousia, 2015). It is estimated the total medical cost accumulated by a hospitalised patient
suffering from an antibiotic resistant infection can reach $29,096 USD (Capita & AlonsoCalleja, 2013). Ineffective antibiotics are predicted to cost more than $55 billion per year
solely in the USA, taking into account the combined cost of health care and lost productivity
(Smith & Coast, 2013). The global cost of antimicrobial resistance is expected to rise to $100
trillion by 2050 (Watts et al., 2017).

2.1.3 Development of New Antibiotics
Global production and discovery of new antibiotic classes has been in decline since the
1970s (Laxminarayan et al., 2013). Pharmaceutical companies are concentrating their efforts
in developing drugs which offer greater prospective economic returns, for instance drugs that
must be taken daily over the course of a person’s life (Collignon, 2015). Long term profits are
further reduced by the inevitable development of resistance to new antibiotics (WHO, 2015).
With minimal options in line for the discovery of new drugs, the preservation of current
available antibiotics is imperative to protect public health.

2.1.4 Action Plans to Prevent Antibiotic Resistance
Antibiotic resistance can spread across country borders through the export of goods,
international travel of people and through environmental media such as water or soil (Barlam
& Gupta, 2015). In 2015, the WHO adopted a global action plan on antimicrobial resistance
with the aim to ensure that modern medicine remains a viable option to treat and prevent
disease (WHO, 2015). Further, in 2017 the WHO developed guidelines on the use of
medically important antimicrobials in food-producing animals, calling for a reduction or ban
on the use of specific antibiotics across the agricultural industry, in order to preserve these
important antibiotics for human medicine (WHO, 2017c).
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In line with suggestions outlined by the WHO, numerous countries have developed their own
national plans and strategies to control and monitor antibiotic resistance, including the USA
and within the European Union (EU) (Economou & Gousia, 2015). In Australia, the
Australian Government implemented Australia’s First National Antimicrobial Resistance
Strategy, Responding to the Threat of Antimicrobial Resistance, which will be in effect until
2019 (Department of Health & Department of Agriculture, 2015). The strategy outlines
priority areas for action, advocating for a coordinated cross-sectoral response. Anticipated
change for Australian aquaculture includes provision of an antimicrobial stewardship
programme, implementation of guidelines for appropriate antibiotic use and the
establishment of information for infection prevention and control options specific to the type
of animal species (Department of Health & Department of Agriculture, 2015).

2.2 Seafood Consumption Trends and Aquaculture
Seafood is endorsed as a beneficial diet choice since it contains high levels of protein,
vitamins and omega-3 fatty acids, which are associated with positive health benefits for the
consumer, such as a reduced risk of heart disease (Elbashir et al., 2018). The global
consumption of seafood per capita is increasing (FAO, 2016). In Australia, the amount of
seafood consumed annually has increased since 2000 (Department of Agriculture and Water
Resources [DAWR], 2015). To meet this demand, the aquaculture industry developed
rapidly and is the fastest growing industry which produces animals for food (Boss,
Baumgartner, & Overesch, 2016). Aquaculture, also referred to as fish farming, is defined as
the practice of raising, breeding and harvesting aquatic organisms with the utilisation of
interventions to improve production results (Sapkota et al., 2008). In line with global trends,
Australia’s aquaculture industry is growing, particularly farmed salmon, prawns and oysters
(Australian Bureau of Agricultural and Resource Economics and Sciences [ABARES], 2017).

In Australia, local seafood suppliers are not able to meet the required production output
desired by the consumer, thus 67% of the total seafood consumed in Australia in 2015-2016
was imported (ABARES, 2017). Furthermore, imported goods from Asian countries satisfy
the Australian consumers’ desire for cheap seafood. Developing countries generally farm
lower-value seafood and can produce cheaper products with inexpensive labour costs and
minimal environmental regulations, which often restrict and financially constrain production in
developed countries (DAWR, 2015). Accordingly, the greatest volume of seafood consumed
in Australia is sourced from Thailand, China and Vietnam (ABARES, 2017). Popular edible
seafood imports in Australia are canned tuna, frozen prawns or shrimp and frozen fish fillets
(Farmery, Gardner, Green, Jennings, & Watson, 2015). The most frequently consumed
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imported fish is basa, a catfish of the Pangasiidae family, which is a low-priced, white flesh,
boneless fish sourced from Vietnamese aquaculture (DAWR, 2015).
2.3 Antibiotic Usage in Aquaculture
2.3.1 Antibiotic Purpose
Aquaculture practice is generally intensive to semi-intensive in nature, meaning that a high
density of fish are stocked in small areas (Santos & Ramos, 2016). Overcrowded conditions
are stressful for the fish, causing lowered immunity which in turn contributes to the incidence
and spread of bacterial infections throughout the stock (Cabello, Godfrey, Buschmann, &
Dölz, 2016). The transmission of disease in farmed aquatic animals is further facilitated by
diminished water quality and poor hygiene practices. In certain regions, pond water is
contaminated with uneaten food, terrestrial animal manure or faeces from the aquatic
animals or humans (Boss et al., 2016; Mo, Chen, Leung, & Leung, 2015). Chemical and
biological products, for example antibiotics, disinfectants and probiotics, can be applied to
mitigate the risk of disease and to improve production (Rico et al., 2012). Antibiotics are
often the favoured option for fish farmers since they are cost effective (Liu, Steele, & Meng,
2017). Aquatic animals are generally medicated orally by the consumption of food mixed
with drugs or, less commonly, animals are injected directly or dosed in a bath treatment
(Thuy, Nga le, & Loan, 2011).

Antibiotics are used to alleviate the risk of disease-related death in fish stocks (Boss et al.,
2016; Mo et al., 2015). For instance, the Chinese aquaculture industry loses roughly 7.5–15
billion USD every year from infectious bacterial outbreaks (Liu et al., 2017). To stop the
threat of disease, antibiotics can be used as a prophylactic over a long period of time in
small doses (Economou & Gousia, 2015). To control an outbreak, the whole stock can be
dosed to prevent the illness from spreading, even if only a minor portion of the stock display
symptoms (Capita & Alonso-Calleja, 2013). Additionally, farmers are financially motivated to
enhance production and can apply antibiotics at a low dose for growth promotion purposes
(Cabello et al., 2013). The theory suggests constant antibiotic ingestion will maintain low
numbers of commensal microflora in the intestines, allowing for increased absorption in the
gut lining, thus boosting the nutrient digestibility of food and increasing weight gain in the
animal (Mo et al., 2015). However, the success of antibiotics to increase feed efficiency and
boost growth rates in fish has been questioned and requires further research (Done et al.,
2015).

Broadly speaking, developing and developed countries have considerable differences in
aquaculture practices (Sapkota et al., 2008). There are multiple factors related to country of
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location that can influence a farmer’s decision to use antibiotics in aquaculture including
legislation, knowledge, farming practices and enforcement activity (Table 1). In general,
antibiotic use is routine in the aquaculture industry in Asian countries which produce 90% of
the global farmed fish for human consumption (Rico et al., 2012).

Table 1. Factors that may influence the likelihood of a farmer misusing or overusing
antibiotics on the aquatic animals in aquaculture to control disease.
Decreased likelihood

Increased likelihood

Legislation to control use

No legislation to control use

Enforcement of legislation

No enforcement activity to control use

Prescription only access

No requirement for a prescription for purchase

Food testing procedures for residues

No food testing procedures for residues

Farmer knowledge of purpose of use

Inadequate knowledge of purpose of use

Labelling in the farmers language

Writing in a language foreign to the farmer

Labelling information with directions for use

Incomplete labelling information on use

Veterinary advice available

Limited access to veterinary professionals

Hygienic facility design

Integrated fish farming with animals

Access to vaccinations

No access to vaccinations

Clean pond water

Water contaminated with agricultural waste and
run-off

Note. Adapted from Chuah, Effarizah, Goni, and Rusul (2016), Henriksson et al. (2018), Pruden et al.
(2013) and Rico et al. (2012).

2.3.2 Regulation and Enforcement Activity
The use of antibiotics in the aquaculture industry is heavily regulated and controlled in
economically developed regions, inclusive of the EU, Japan and North America (Watts et al.,
2017). Developed countries are generally guided by legislation which stipulates which
antimicrobials can be used in aquaculture and access is limited to prescription under the
guidance of qualified personnel (Quesada, Paschoal, & Reyes, 2013). It is usually illegal to
apply antibiotics for growth promotion purposes in animals (Nachman, Smith, & Maron,
2013). Developed countries enforce food testing procedures and legislative requirements
that imported and local products must meet. For instance, aquaculture farmers outside the
EU who wish to export their products into the EU are required to provide and implement a
control plan for the use of veterinary products and the plan must be approved and renewed
yearly (European Commission, 2018).
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In contrast, antibiotic use in the Asian aquaculture industry is not always legally regulated,
resulting in routine use (Rico et al., 2012). Asian aquaculture was established rapidly and the
provision of legislation to control chemical use has failed to keep up with industry growth and
regulation requirements are varied (Rico et al., 2012). In 2016, there were no legal standards
for regulatory limits to control the presence of antibiotic residues in seafood sold in Thailand
(Jansomboon, Boontanon, Boontanon, Polprasert, & Thi Da, 2016). Legislation in China is
not considered stringent in comparison to the United Kingdom which has minimal legal
options available and a broad range of antibiotics are permitted for use in Chinese
aquaculture (Liu et al., 2017). Furthermore, there are minimal inspections of Chinese
aquaculture farms and penalties for noncompliance are either insignificant or not actively
enforced (Santos & Ramos, 2016).

Moreover, farmers in developing countries without active regulation of the pharmaceutical
industry are often supplied poorly labelled, low-quality or imitation antibiotics. Counterfeit
antibiotics are commonly produced and consumed in Southeast Asia (Zellweger et al.,
2017). Poor quality drugs often fail and have been associated with contributing to the spread
of antibiotic resistance genes (Laxminarayan et al., 2013). Misuse of antibiotics also arises
from unclear directions on antibiotic labels, with missing information or instructions written in
language foreign to the farmer (Rico et al., 2012).

2.3.3 Knowledge and Availability
There is a stark difference in knowledge and disease control options between the
aquaculture industries in developed and developing countries. Developed countries are not
as reliant on antibiotics since there are other available options to control and prevent
disease, such as vaccination and good facility design (Pruden et al., 2013). Norway
successfully reduced its reliance on antibiotics to control disease in salmon farms by
implementing vaccination against disease and by improving hygiene standards across the
board (Chuah et al., 2016). Similarly, the Tasmanian aquaculture industry is using
significantly less antibiotics since the introduction of a vaccine implemented to prevent the
development of diseases caused by the bacterial genera Vibrio and Yersinia (Department of
Health & Department of Agriculture, 2015).

In contrast, ease of antibiotic availability and purchase, coupled with poor understanding by
fish farmers further exacerbates the misuse and overuse of antibiotics in developing
countries (Uchida et al., 2016). A previous study found fish farmers could easily obtain and
purchase antibiotics, including banned substances (Mo et al., 2015). Excessive use of
antibiotics has been observed in Thailand and Vietnam with over 70% of fish or shrimp
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farmers admitting to using one or more antibiotics in their production cycle (Zellweger et al.,
2017). Fish farmers in Vietnam and Thailand have demonstrated inappropriate use of
antibiotics, without prior knowledge of the correct type of antibiotic required, dosage or
purpose of use (Chitmanat, Lebel, Whangchai, Promya, & Lebel, 2016; Nguyen Dang Giang
et al., 2015). A rushed decision to diagnose and treat disease can result in the application of
unsuitable antibiotics which are ineffective to resolve the particular problem (Ryu et al.,
2012). Advice is not generally sought from veterinarians to diagnose and treat disease
appropriately since the service is not easily accessible or it is too expensive for the farmer to
afford (Jansomboon et al., 2016). Farmers with limited knowledge can turn to drug
manufacturers or sellers for advice which can cause the misuse of antibiotics when the
farmer is encouraged to purchase unsuitable antibiotics by salesmen who are solely
motivated to make transactions for personal profit (Pham et al., 2015). Accordingly, the use
of antibiotics in aquaculture creates a risk of antibiotic residue and antibiotic resistant
organism contamination in the environment and seafood products.

2.3.4 Integrated Farming
The practice of integrated farming where aquaculture and agriculture co-exist is common in
developing countries which import seafood to Australia (ABARES, 2017; Mo et al., 2015;
Pham et al., 2015). Antibiotics are often indirectly introduced into aquatic ponds when they
are contained in animal waste which is applied to feed the animals and encourage growth
(Pruden et al., 2013; Watts et al., 2017). High concentrations of antibiotics have been
reported in the waste from swine, cattle and chickens (Qiao et al., 2018; Watts et al., 2017).
Combined farming of ducks or chickens with fish ponds often occurs where the bird pen is
situated on top of the water with an outlet to release the manure directly into the fish pond
(Huang et al., 2017; Watts et al., 2017). Accordingly, previous studies found higher
concentrations of antibiotics in water at aquaculture facilities with integrated farms, in
comparison to the water at non-integrated aquaculture facilities (Zhong et al., 2018).

2.3.5 Environmental Contamination
The majority of aquaculture facilities are connected to surrounding water sources, providing
a contamination risk when the farm discharges wastewater (Done et al., 2015). Surrounding
soil and sediment can become contaminated through absorption of antimicrobial agents
expelled in wastewater (Deng et al., 2016). The water stream can also become directly
polluted when uneaten medicated food is leached from the farm or antimicrobial metabolites
and antimicrobial agents which are ingested but not absorbed, are excreted in animal urine,
stools or secretions (Cabello et al., 2016). It is estimated that approximately three quarters of
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antibiotics in feed contaminate the environment via animal excretions and uneaten feed
(Rico et al., 2012). Waste products can be transported via underwater currents to more
distant locations, facilitating the spread of antibiotic residues in the environment (Buschmann
et al., 2012).

It is possible for wild aquatic life in areas surrounding farms to encounter and consume
antimicrobial agents escaped from aquaculture (Figure 1) (Cabello et al., 2013; Thuy et al.,
2011). Wild fish caught in water surrounding aquaculture facilities have been found to
contain antibiotic residues, such as tetracyclines (Cañada-Cañada, Muñoz de la Peña, &
Espinosa-Mansilla, 2009). Other sea animals, including crustaceans and shellfish, have also
ingested antibiotics from the environment adjacent to aquaculture (Thuy et al., 2011). In the
USA, farmed Atlantic salmon labelled ‘antibiotic free production’ were found to contain low
levels of virginiamycin, an antibiotic commonly used in agriculture (Done & Halden, 2015).

It can be challenging to assess the extent of antibiotic accumulation in the environment and
the length of time they can remain active since antibiotic degradation is influenced by a
range of factors including temperature and light (Thuy et al., 2011). Different antibiotics have
different resistance to the biodegradation process (Mo et al., 2015). For instance,
sulfamethoxazole has low biodegradability and as a result it can contaminate the
environment for lengthy periods (Jansomboon et al., 2016). Oxolinic acid degrades rapidly in
pond water which is illuminated naturally, in comparison to water with less light (Thuy et al.,
2011). Antimicrobials have been found to remain persistent for months in the environment by
staying active in sediment (Cabello et al., 2013).

2.3.6 Human Exposure to Antibiotic Residues
Humans can be exposed to antibiotic residues via contact and consumption of wild or
farmed aquatic organisms, and through contact with contaminated swimming and drinking
water (Figure 1) (Chuah et al., 2016; Mo et al., 2015). Contact can occur with the polluted
water supply or by ingestion of food containing drugs and sediment. The risk of antibiotic
residues contaminating drinking water is considerably lower in developed countries with
access to treated drinking water systems. The risk is increased in underdeveloped countries
where there is limited clean and treated drinking water (Lundborg & Tamhankar, 2017;
Quesada et al., 2013). For instance, rurally located Vietnamese drink from surface water
which can be contaminated with antibiotics originating from agriculture (Nguyen Dang Giang
et al., 2015). It is difficult to minimise the risk to the consumer by consumption since cooking
does not always destroy or reduce antibiotic residues in food animals (Fletcher, 2015).
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Figure 1. Flow Chart outlining the entry and exit points for antimicrobials into the
environment from aquaculture, and potential sources of human exposure. Note. Adapted
from Chuah et al. (2016) and Mo et al. (2015).

2.3.7 Adverse Drug Reaction
Adverse drug reaction, allergic reaction or chronic toxicity, are potential negative health
effects associated with human exposure to antibiotic residues through consumption of
aquaculture products (Liu et al., 2017). Inadequate toxicology data and inconsistent
standards across countries make it difficult to determine the extent of the health risk
associated with antibiotic residues in food (Chen et al., 2015). The Codex Alimentarius
Commission, created by the WHO and the FAO, provide some international standards for
maximum residue limits (MRL) and acceptable daily intake (ADI) of veterinary drugs in food
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of animal origin deemed acceptable to prevent risk to public health (Codex Alimentarius
Commission, 2017). There is an additional unknown risk to human health through the
consumption of animals contaminated with more than one antibiotic since current food safe
guidelines are limited to providing ADI for exposure to individual antibiotics only (Zhang et
al., 2018).

There is a risk to human health if an allergic person consumes seafood contaminated with
extremely high levels of antibiotic residues as a number of antibiotics used in the
aquaculture industry, such as tetracycline, sulfonamides and penicillin, could initiate an
allergic reaction in sensitive people (Liu et al., 2017; Mo et al., 2015). Potential allergic
symptoms can include hives, abdominal pain and vomiting (Liu et al., 2017). Severe cases of
allergic reaction can result in anaphylactic shock which may cause death (Quesada et al.,
2013). Nevertheless, it is considered an extremely rare occurrence for a person to suffer an
allergic reaction from the consumption of meat containing antibiotic residues (Aitken et al.,
2016). For example, anaphylaxis was documented in a male who consumed steak
contaminated with penicillin (Woodward, 2005). A similar report found a person suffered an
allergic reaction prior to the consumption of beef contaminated with streptomycin
(Woodward, 2005).

Another risk to human health is from toxic effects in the body caused by antibiotic residues
(Mo et al., 2015; Okocha et al., 2018). The potential negative health impacts are dependent
on the type and concentration of the antibiotic used. For instance, erythromycin exposure
may be linked to ototoxicity (Liu et al., 2017). Due to toxicity concerns there are restrictions
on the use of antibiotics deemed a threat to human health. Numerous countries have
banned the use of nitrofuran in the production of food animals due to concerns that residues
can remain in the edible tissue of the animal, potentially triggering carcinogenic effects in
humans when consumed, since nitrofurans have been deemed mutagenic and nephrotoxic
(Elbashir et al., 2018; Oliveri Conti et al., 2015). Chloramphenicol is not permitted for use on
food animals in several countries including Australia, China and the USA since aplastic
anaemia and leukaemia have been associated with chloramphenicol exposure, and even
low levels of exposure can be harmful (Cañada-Cañada et al., 2009; Hanekamp & Bast,
2015; Kathleen et al., 2016; Mo et al., 2015).

2.4 Australian Regulation and Control of Antibiotic Use in Food Animals
2.4.1 Australian Regulations
Australia has definitive national legislation to regulate drug residues in food and to oversee
antibiotic use in the food animal industry (DAWR, 2015). Antimicrobial use in livestock
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animals in Australia is governed and strictly controlled by the Australian Pesticides and
Veterinary Medicines Authority (APVMA, 2017). Although there are no antibiotics registered
for use in Australian aquaculture, the APVMA can issue minor use permits at their discretion
(APVMA, 2017).

Aquatic animals for sale for human consumption in Australia must comply with the Australia
New Zealand Food Standards Code (ANZFSC), irrespective of the country of origin. In
Western Australia, the Food Act 2008 (WA) and the Food Regulations 2009 (WA) adopt the
ANZFSC. Seafood must not contain antibiotic residues unless expressly permitted, and
within the prescribed limits, as prescribed in Standard 1.4.2 and Schedule 20 of the ANZFSC
(Table 2) (FSANZ, 2016). Seafood for human consumption which contains traces of any
veterinary chemicals, including antibiotics, at a concentration which is not permitted under
the ANZFSC is deemed as unsuitable in accordance with section 13(1)(d) of the Food Act
2008 (WA) and must not be sold.

Table 2. Permitted antibiotic residues in seafood for sale in Australia.

Antibiotic Name

Type of Seafood Sample

Maximum Allowable Limits (mg/kg)

Florfenicol

Fish

0.5

Oxytetracycline

Fish

0.2

Tylosin

Fish muscle

0.002

Note. Adapted from the FSANZ (2016).

2.4.2 Australian Border Testing Scheme
The Australian Government routinely tests imported food in compliance with the Imported
Food Control Act 1992 (Cth). The Department of Agriculture and Water Resources (DAWR,
2015) is responsible for ensuring that imported food meets the required food safety
standards under the ANZFSC. Under the Imported Food Inspection Scheme, seafood is
subject to surveillance chemical tests for the presence of antibiotic residues. Each
consignment of seafood has a 5 percent chance of being randomly selected for testing using
electronic profiles where it is subject to testing for the presence of certain antibiotics. The
protocol for testing differs depending on the seafood type (Table 3) (DAWR, 2016).
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Table 3. Surveillance chemical testing conducted on imported seafood at the Australian
border by the Department of Agriculture and Water Resources.

Antibiotic Class
Fluoroquinolones

Types of Food

Antibiotic Name

Fish species used in aquaculture and

Ciprofloxacin, enrofloxacin,

farmed crustaceans

gatifloxacin, levofloxacin,
moxifloxacin, norfloxacin,
ofloxacin, sarafloxacin

Quinolones

Fish species used in aquaculture

Flumequine, oxolinic acid

Nitrofurans

Farmed crustaceans

Furaltadone, furazolidone,
nitrofurantoin, nitrofurazone

Note. Adapted from the DAWR (2016).

2.5 Occurrence of Antibiotic Residues in Seafood
2.5.1 Global Studies
A variety of antibiotics, in different concentrations, were detected in shrimps, crabs, molluscs
and fish sold in China, Thailand, the USA, South Korea and Vietnam (Table 4) (Chen et al.,
2015; Jansomboon et al., 2016; Kang et al., 2018; Liu, Lu, Meng, & Zheng, 2018; Pham et
al., 2015). Even antibiotics which are banned for use in aquaculture have been previously
detected in seafood samples, such as chloramphenicol in aquatic organisms from China (Liu
et al., 2017). The majority of the samples in the previous studies are non-compliant with
Australian food safety legislation which stipulates that only three antibiotic types are
permitted in seafood, any other antibiotic is not permitted at any level (Section 2.4). Of the
32 types of antibiotics detected in global studies, only florfenicol and oxytetracycline are
permitted, within prescribed limits, in seafood sold in Australia (FSANZ, 2016). The fish
analysed in South Korea contained residues of florfenicol and oxytetracycline below the
maximum allowable limits stipulated in the ANFSC, and therefore would be compliant if sold
in Australia (Kang et al., 2018).
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Table 4. Antibiotic residues detected in aquatic organisms in global studies. Antibiotic types
permitted, within limits, in seafood sold in Australia are underlined (FSANZ, 2016).
Country of Study

Antibiotic Type Detected

Aquatic Organism

Origin of product
China

Year

Reference

Type
CIP, CLR, EN, ERY, FLE,

Fish, crabs,

NAR, OFL, OXY, SAL, SXZ,

molluscs and

SDX, SDZ, SZE, SZO, SOX,

shrimp

2015

Chen et al.
(2015)

TMP,
China

CIP, EN, FLU, LO, NOR, PEF

Fish

2017

Song et al.
(2017)

China

EN, SXZ, SMZ, SAR, SDZ,

Fish and shrimp

2018

TMP,
South Korea

Liu et al.,
(2018)

AMX, CIP, CTE, EN, ERY,

Fish

2018

FLO, NAL, OA, OM, OXY,

Kang et al.
(2018)

SXZ, SMZ, SDZ, SPI, SDX,
TET, TMP
Thailand

SMZ, SXZ, SDZ, SMY

Fish

2016

Imported from

Jansomboon
et al. (2016)

Vietnam
The United States

OM, OXY, SDX, VI

Fish and shrimp

2015

Mix of local and

Done and
Halden (2015)

imported products
Vietnam

CIP, EN, NOR, OXY

Fish and shrimp

2015

Pham et al.
(2015)

Vietnam

CIP, EN, NOR, OFL, OA,

Fish and shrimp

SMZ, SXZ, TMP

2016

Uchida et al.
(2016)

Legend (Antibiotic abbreviations): AMX, amoxicillin; CTE, chlortetracycline; CIP, ciprofloxacin; CLR,
clarithromycin; EN, enrofloxacin; ERY, erythromycin; FLE, fleroxacin; FLO, florfenicol; FLU,
flumequine; LO, lomefloxacin; NAL, nalidixic acid; NAR, narasin; NOR, norfloxacin; OFL, ofloxacin;
OM, ormethoprim; OA, oxolinic acid; OXY, oxytetracycline; PEF, pefloxacin; SAL, salinomycin; SAR,
sarafloxacin; SPI, spiramycin; SDZ, sulfadiazine; SDX, sulfadimethoxine; SZE, sulfamerazine; SMZ,
sulfamethazine; SXZ, sulfamethoxazole; SMY, sulfamethoxydiazine; SZO, sulfathiazole; SOX,
sulfisoxazole; TET, tetracycline; TMP, trimethoprim; VI, virginiamycin.

2.5.2 Australian Studies
In Australia, there have been limited nongovernmental studies analysing the presence of
antibiotic residues in domestic and imported seafood. The 2016-17 National Residue Survey
conducted by the DAWR (2017a) analysed 208 Australian fish samples for a range of
14

chemicals, including antibiotics such as aminoglycosides, cephalosporins, macrolides,
nitrofurans, sulfonamides and tetracyclines. High levels of compliance were observed; all the
wild caught fish (n=70) and the majority (98.55%) of the aquaculture fish (n=138) did not
contain traces of chemical residues (DAWR, 2017a).

The Australian Quarantine and Inspection Service (AQIS) survey conducted between 2006
and 2007 assessed imported seafood products which arrived at Perth, Sydney, Melbourne
or Brisbane for a broader range of antibiotic residues. Thirty-one percent of the 100 samples
were found to contain residues of one or more antibiotics at levels which are too low to
cause toxic effects in the consumer (Australian Quarantine and Inspection Service, 2008).
The detections were non-compliant with the ANFSC which does not allow any level of
antibiotic residues in seafood, with the exception of the samples containing oxytetracycline
(FSANZ, 2016). The noncompliant samples all originated from five of the top six countries
which import the greatest volume of edible seafood into Australia (Table 5).

Table 5. AQIS Survey antibiotic detection results in seafood.
Antibiotic Name

Number of Detections

Type of Seafood

Country of Origin

Florfenicol

1

Prawns

China

Enrofloxacin

2

Prawns

China

Ciprofloxacin

1

Prawns

China

Flumequine

6

Prawns and fish

China, Indonesia,
Thailand and Vietnam

Oxytetracycline

7

Prawns, crab and fish

China, Indonesia,
Thailand and Vietnam

Sulfamethoxazole

5

Prawns

China

Sulfameter

1

Eel

China

Sulfamethazine

1

Eel

China

Sulfadimethoxine

1

Eel

China

Sulfamethoxypyridazine

1

Eel

China

Amoxicillin

11

Fish and crab

Indonesia and New
Zealand

Ampicillin

3

Fish

New Zealand

Note. Adapted from Australian Quarantine and Inspection Service (2008).
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2.6 Antibiotic Resistance and Antibiotic Use in Aquaculture
2.6.1 Sources of Bacterial Contamination
Aquaculture facilities and the surrounding area host a vast range of bacterial genera
(Kathleen et al., 2014). The bacteria can be harmless to humans or fish, or they can be
opportunistic pathogens (Novoslavskij et al., 2016). Pathogenic bacteria in the aquatic
environment can be naturally present such as the native habitat of Vibrio species is water
and pathogenic strains of this species cause foodborne illness (Sudha, Divya, Francis, &
Hatha, 2012). Pathogenic bacteria can enter the water from terrestrial sources including
discharged industrial waste and sewerage (Cabello et al., 2016). Bacteria can potentially be
introduced to fish ponds when human or animal faecal matter are added to the water and
from the application of homemade fish feed made from food scraps and animal offal (Budiati
et al., 2013; Pruden et al., 2013). Furthermore, integrated farming of livestock with
aquaculture introduces animal manure directly into the water which creates a risk of faecal
pathogens, such as Clostridium difficile, contaminating the fish (Putsathit, Kiratisin,
Ngamwongsatit, & Riley, 2015; Watts et al., 2017). Aquatic organisms are at risk of bacterial
contamination by the ingestion of polluted material or direct contact with contaminated water,
sediment and feed (Novoslavskij et al., 2016). There is an additional risk that seafood can be
contaminated with bacteria from improper handling and poor hygiene practices during
transport, preparation or storage (Elbashir et al., 2018; Noor Uddin, Larsen, Guardabassi, &
Dalsgaard, 2013).

2.6.2 Bacteria Developing Antibiotic Resistance
Bacteria can develop antibiotic resistance in response to the selective pressure created by
the inappropriate and widespread use of antibiotics in aquaculture (Cabello et al., 2013).
Causal relationships have been observed between the types of antibiotics used and the rise
in resistance to these antibiotics (Ryu et al., 2012). The aquatic environment has been
identified as a significant reservoir of antibiotic resistance genes, disseminating antibiotic
resistance between different bacterial species (Marti et al., 2014). Mechanisms of horizontal
gene transfer can facilitate the spread of antibiotic resistance genes between pathogenic
and non-pathogenic bacteria (Mo et al., 2015). Multidrug resistant genes have been
transferred to Escherichia coli (E. coli), a pathogen which causes disease in humans, from
A. salmonicida through the mechanism of conjugation (Elbashir et al., 2018).

Previous studies have identified antibiotic resistant bacteria from seafood or the aquaculture
environment more generally in Australia, Switzerland, Korea, Vietnam, Malaysia, China,
India and Denmark (Akinbowale, Peng, & Barton, 2006; Akinbowale, Peng, Grant, & Barton,
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2007; Boss et al., 2016; He, Jin, Sun, Hu, & Chen, 2016; Kang et al., 2016; Kathleen et al.,
2016; Nguyen et al., 2014; Noor Uddin et al., 2013; Ryu et al., 2012; Sudha et al., 2012;
Yang et al., 2015). A range of bacteria including potentially pathogenic species, such as E.
coli, Vibrio, Salmonella, Pseudomonas, Serratia, Acinetobacter and Aeromonas, have
demonstrated resistance to a variety of antibiotics from various antibiotic classes, including
penicillins, cephalosporins, sulfonamides, aminoglycosides, tetracyclines and quinolones
(Table 6).
Table 6. Antibiotic resistance observed in bacterial isolates obtained from seafood and
aquaculture settings, listed in alphabetical order by the country of study.
Country of
Study
Australia

Bacterial genera
or species
Predominately
Vibrio &
Aeromonas

Source of
Bacteria
Farmed fish,
crustaceans &
water

Australia

Pseudomonas &
Aeromonas

Farmed fish &
sediment

China

Vibrio
parahaemolyticus
Salmonella

Shrimp

Aeromonas
hydrophilia
Salmonella

Fish

Predominately
Pseudomonas,
Serratia &
Exiguobacterium
Vibrio
parahaemolyticus
Predominately
Bacillus,
Staphylococcus,
Acinetobacter &
Pseudomonas
Vibrio
parahaemolyticus
Escherichia coli

Fish and shrimp
from Denmark
and imported
from Asia
Oysters

China

China
China
Denmark

Korea
Malaysia

India
South
Korea

Fish, shrimp &
oysters

Fish

Fish, shrimp,
sediment &
water

Fish
Fish, shellfish,
molluscs
& crustaceans
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Antibiotic Class

Reference

AMP, AMX, CXN, CEF,
CF, CHL, FLO, NA, OA,
GT, KN, ERY, TET,
OXY, TMP, SXZ, T-S
AMX, CEF, CF, TI,
OXY, FLO, S, SXZ, CT,
OA, CHL, TMP, NIT
AMP, S, RIF, SPT,

Akinbowale et
al. (2006)

AMP, AMC, CEF, CHL,
TET, NAL, S, KN, T-S,
CZL
AMP, CIP, KN, NAL, S,
TET
AMP, ERY, GT, NAL,
NIT, PEN, S, TET, TMP
AMP, ERY, AMC, CEZ,
T-S, TET, CF, CT

Yang et al.
(2015)

AMP, CEF, S, ERY,
RIF, VAN
S, AMP, PEN, ERY,
CEF, RIF, NIT, PIP,
CRO, CEZ

Kang et al.
(2016)
Kathleen et al.
(2016)

AMP, AMX, CAR, CPD,
CEF, COL, S
TET, S, CIP, AMP, T-S,
TI, NAL, KN, CHL

Sudha et al.
(2012)
Ryu et al. (2012)

Akinbowale et
al. (2007)
He et al. (2016)

Yang et al.
(2018)
Broughton and
Walker (2009)
Noor Uddin et
al. (2013)

Switzerland

Vietnam

Predominately
Escherichia,
Enterococcus,
Pseudomonas &
Staphylococcus
Pseudomonas &
Aeromonas

Fish, shrimp &
oysters

CIP, NAL, TET, SXZ,
AMP, TMP, CHL, PEN,
KN, GEN

Boss et al.
(2016)

Fish, water and
sediment

AMP, T-S, CHL, NIT,
NAL, CIP, NOR, TET,
DOX, GT, S, KN

Nguyen et al.
(2014)

Legend (Antibiotic abbreviations): AMX, amoxicillin; AMC, amoxicillin-clavulanic acid; AMP, ampicillin;
CAR, carbenicillin; CXN, cefalexin; CEF, cefalotin; CZL, cefazolin; CT, cefotaxime; CPD,
cefpodoxime; CEZ, ceftazidime; CF, ceftiofur; CRO, ceftriaxone; CHL, chloramphenicol; CIP,
ciprofloxacin; COL, colistin; DOX, doxycycline; ERY, erythromycin; FLO, florfenicol; GT, gentamicin;
KN, kanamycin; NA, nalidixic acid; NIT, nitrofurantoin; NOR, norfloxacin; OA, oxolinic acid; OXY,
oxytetracycline; PEN, penicillin; PIP, piperacillin; RIF; rifampicin; SPT, spectomycin; S, streptomycin;
SXZ, sulfamethoxazole; TET, tetracycline; TI, ticarcillin; TMP, trimethoprim; T-S, trimethoprimsulfamethoxazole; VAN, vancomycin.

2.6.3 Intestinal Microflora
The composition of human or animal intestinal microflora can be altered by exposure to
antibiotics (Chuah et al., 2016). A previous study found the ingestion of low-levels of
antibiotics over extended periods of time could cause antibiotic resistance to occur in
intestinal microflora (Liu et al., 2017). The analysis of human faecal metagenomes found
antibiotic resistance genes were on average more frequent for antibiotics used in agriculture
as well as human medicine (Forslund et al., 2013). Enteric bacteria harbouring antibiotic
resistance genes can multiply in the gastrointestinal tract before they are released in the
effluent of humans and animals, potentially disseminating in the environment, particularly in
locations with inadequate sanitation, creating risk of human exposure and subsequent
infection (Finley et al., 2013).

2.6.4 Human Exposure and Infection
Humans are at a risk of exposure to antibiotic resistant bacteria sourced from agriculture
through the ingestion of contaminated products, including raw or undercooked seafood and
drinking water (Elbashir et al., 2018). A study in the Netherlands determined similar antibiotic
resistant genes in Enterobacteriaceae isolated from multiple hospital patients, biological
samples and fresh meat products, suggesting a potential relationship between consumption
and colonisation in the gut (Overdevest et al., 2011). Drinking water in less developed
regions without adequate disinfection procedures are more likely to contain antibiotic
resistant bacteria, particularly water which is sourced from polluted supplies tainted with
human or animal waste (Manaia, Macedo, Fatta-Kassinos, & Nunes, 2016).
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Populations who are at a higher risk of exposure to zoonotic, antibiotic resistant bacteria
include farm and veterinary workers who have direct contact with contaminated animals and
farm areas (Economou & Gousia, 2015). Antibiotic resistant bacteria can spread to hands
and mouths by contact with contaminated surfaces, animals and excreta (Aitken et al.,
2016). Direct contact with bacteria on fish with open wounds is a risk of infection for food
handlers or aquaculture workers (Alderman & Hastings, 1998). Cross contamination can
occur in the kitchen transferring bacteria from raw seafood products to ready to eat foods
(Capita & Alonso-Calleja, 2013). Poor hygiene and food handling practices, such as direct
contact with contaminated cleaning products, handles, utensils, hands, clothing and other
surfaces, can facilitate the spread of bacteria around the kitchen and onto food products,
placing the consumer at risk of foodborne infection (Stein, 2011).
2.7 Study Purpose and Objectives
The majority of the seafood consumed in Australia is imported from Asian countries where
antibiotic use is common and often unregulated (ABARES, 2017; Chen et al., 2015;
Jansomboon et al., 2016; Oliveri Conti et al., 2015; Uchida et al., 2016). The use of
antibiotics in aquaculture is associated with an increase in antibiotic resistant bacteria in the
aquatic environment (Rico et al., 2013). Previous studies conducted in countries which
supply seafood to Australia have identified antibiotic resistance in pathogenic bacteria
isolated from seafood (ABARES, 2017; He et al., 2016; Yang et al., 2015). There is a
potential risk to the consumer as 95% of seafood imports into Australia are not tested for
antibiotic residues and those that are tested are only analysed for a small range of
antibiotics, and routine Australian border testing does not analyse food of animal origin for
the presence of antibiotic resistant bacteria (DAWR, 2016).

This study was conducted to address a current gap in knowledge regarding the occurrence
of antibiotic resistant bacteria and antibiotic residues in locally and internationally sourced
fish sold in Australia. The objectives of this study were:


To investigate whether antibiotic residues are present in seafood for sale in Western
Australia.



To analyse the occurrence of antibiotic resistance (8 antibiotics) in Gram negative
bacteria isolated from fish samples sold in Perth, Australia.



To determine whether country of origin correlates with the presence of antibiotic
residues and antibiotic resistant bacteria in seafood samples.
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3.0 Methodology

3.1 Antibiotic Residues in Seafood Data
Historical data regarding the presence of antibiotic residues in seafood samples was
accessed from the Local Health Authorities Analytical Committee (LHAAC) Coordinated
Sampling Project 20, Antibiotic and Heavy Metal Residues in Seafood Products (Local
Health Authorities Analytical Committee, 2017). Between May and June 2017, 253 samples
of fish, crustaceans and molluscs were collected across 32 Western Australian Local
Government areas located regionally and throughout metropolitan Perth (Figure 2).

Figure 2. Map of Perth metropolitan area (red outline) within the WA map
noting the Local Government bodies which collected seafood samples for analysis.
Note. Adapted from Google (2018).
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The samples were analysed by Liquid Chromatograph Triple Quadrupole Mass
Spectrometer (LC-MS/MS) for the presence of amoxicillin, ampicillin, cefalexin, cefalotin,
erythromycin, oxytetracycline, sulfamethoxazole and trimethoprim, above the limit of
reporting (LOR) (Table 7). The maximum allowable limits are determined by the ANZFSC.
Where there are no limits stipulated, then the limit of 0 mg/kg was applied since any amount
is deemed unacceptable (FSANZ, 2016). Analysis was conducted at a National Association
of Testing Authorities (NATA) approved laboratory (ChemCentre, Corner Manning Road and
Townsing Drive Bentley, Western Australia). The antibiotics analysed are defined by the
WHO as either critically or highly important antimicrobials for human medicine and should be
used sparingly in the agriculture industry to maintain their effectiveness for treating human
infection (WHO, 2017a).

Table 7. Antibiotic type, importance classification of antibiotic by the WHO, residue LOR and
the maximum allowable limits.

Analyte

Importance
Classification of
Antibiotic

LOR

Maximum allowable limits (mg/kg)

(mg/kg)

Fish

Crustaceans

Molluscs

Amoxicillin

Critically Important

0.02

0

0

0

Ampicillin

Critically Important

0.03

0

0

0

Oxytetracycline

Highly important

0.02

0.2

0

0

Sulfamethoxazole

Highly important

0.02

0

0

0

Trimethoprim

Highly important

0.02

0

0

0

Erythromycin

Critically Important

0.01

0

0

0

Cefalotin

Highly important

0.01

0

0

0

Cefalexin

Highly important

0.03

0

0

0

Note. Adapted from the WHO (2017a) and FSANZ (2016).

3.2 Antibiotic Resistant Bacteria from Fish
3.2.1 Collecting Fish Samples
Fresh and frozen fish samples were purchased from supermarkets and grocery stores
located in ten suburbs in the metropolitan area of Perth, WA (Figure 3). Forty-four “white
flesh” fish products were obtained, 23 of the samples were imported fish and 21 originated
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from Australia. There was a focus on “white flesh” fish, particularly Pangasius since this type
of fish is the most popular imported fish to eat in Australia (DAWR, 2015). The samples were
purchased as filleted fish, the scales were already removed, and the products were prepackaged to minimise the risk of cross contamination from the point of sale. To maintain the
cold-chain, the fish samples were transported in a sealed refrigerated bag containing ice
bricks, to the laboratory at Edith Cowan University (ECU) where they were stored at 4°C in a
sealed and labelled container for up to two days prior to processing. Some fish were
purchased as frozen fillets and these were thawed in the refrigerator at 4°C for up to 24
hours before bacteriological analysis.

Figure 3. Locations in Perth, WA where fish samples were purchased. Note. Adapted from
Google (2018).
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3.2.2 Gram negative Bacteria Isolation
This study focused on isolating Gram negative bacteria, members of the Enterobacteriaceae
family, from the fish samples. Bacteria of the Enterobacteriaceae family were selected as the
focal point of the study since they are commonly found in the aquaculture environment
(Kathleen et al., 2014). Furthermore, the WHO identified antibiotic resistance of
Enterobacteriaceae as a looming threat to public health. Enterobacteriaceae are classified
priority 1 “critical” pathogens on the global priority list of antibiotic-resistant bacteria to guide
research and the development of new antibiotics (WHO, 2017b).

The fish was processed on a surface sterilised with 70% ethanol and lined with a waterproof,
absorbent bench protector. Portions of the fish were removed aseptically with a disposable
scalpel, placed in a sterile plastic petri dish, weighed on scales (Ripe Gourmet Kitchen
Scales, model number 04RI150) and cut into smaller pieces using a disposable scalpel and
a pair of forceps. The forceps were sterilised with 70% ethanol prior to use.

Lennox Luria Bertani Broth (LB broth) was prepared by mixing six grams of LB powder
(Becton Dickinson Pty Ltd, North Ryde, NSW) with 300mL of deionised water in a Schott
bottle. Once prepared, the solution was autoclaved for 20 minutes at 121°C, under 100 kPa
pressure. A 1:10 dilution was made in a sterile 70 mL plastic container by homogenising five
grams of fish and 45 mL of LB broth with a Diax 900 homogeniser (Heidolph Instruments
GmbH & Co.KG, Schwabach, Germany) using speed setting five for 90 seconds. The
standard homogenisation process was optimised by evaluating a series of speed settings
and times to ensure adequate homogenisation and bacteria recovery.

Between each fish sample the homogeniser was completely dismantled, and all adhering
flesh was removed, before components were sterilised using 70% ethanol. Fifty grams of the
remaining portion of fish was stored at -18°C in a plastic zip lock bag. For back up stocks, 1
mL of the 10% fish homogenate was transferred with a sterile micropipette into two aliquots
and frozen in storage at -18°C, and later removed to -80°C storage.

Serial dilutions of 1:100 and 1:1000 were prepared in LB broth and 100 µL of each inoculum
was spread over the surface of MacConkey Agar (MAC) (Edwards Group Pty Ltd, Narellan,
NSW). The prepared plates were labelled and incubated at 37°C for up to 48 hours.

3.2.3 Bacteria Identification
Following the incubation period, photographs were taken of each MAC plate and saved
electronically for a visual record of bacterial growth (Figure 4). Bacterial colonies were
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identified visually on the MAC for similarity in shape, colour, size, elevation, structure, and
edges. The primary focus was to identify for the presence of Enterobacteriaceae colonies,
specifically those that were lactose fermenting such as Escherichia species (spp.). Numbers
of lactose fermenting, purple, and non-lactose fermenting, pink, colonies were enumerated.
The data was recorded in an excel spreadsheet and the estimated MacConkey colony
forming units per gram (MCFU/g) were calculated for all samples.

A maximum of four different colonies grown from each fish sample were selected for further
analysis. The selected colonies were aseptically transferred onto nonselective media,
Trypticase soy agar (TSA) (Edwards Group Pty Ltd, Narellan, NSW), with a sterile loop and
plated for single colonies. The TSA plates were labelled with the date of analysis and a
reference number to identify each plate with its associated fish sample, prior to being
incubated for up to 24 hours at 37°C (Ryu et al., 2012).

Figure 4. Growth of bacteria isolated from fish sample 5A, diluted 1:1000, on MAC after 48
hours incubation.

3.2.3 (i) Gram Stain
Identification tests were conducted on the bacterial isolates to confirm they belonged to the
Enterobacteriaceae family. A Gram stain was the initial identification test conducted. This
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was carried out using standard methods and a Gram Stain Set (Becton Dickinson Pty Ltd,
North Ryde, NSW). A suspension of a single bacterial colony in water was made, air dried
and heat fixed. This smear was stained with Crystal violet for 30 seconds, flooded with
iodine for 30 seconds, decolourised with alcohol acetone for two seconds and flooded with
safranin for 30 seconds, with tap water being used to wash between each staining step. The
slide was blotted dry and analysed using an Olympus CH30 microscope (Olympus
Corporation, Tokyo, Japan) to assess the colour and shape of the bacteria using the oil
immersion lens at x1000. Bacteria were deemed Gram positive if they appeared purple or
Gram negative if they were pink in appearance (Becton Dickinson Pty Ltd., 2017).

3.2.3 (ii) Oxidase Testing
An oxidase test was conducted on all Gram negative bacterial isolates. Bacterial colonies
were picked from the TSA plate with a toothpick or a plastic disposable loop and smeared
onto a Microbact oxidase strip (Oxoid Australia Pty Ltd, Thebarton, SA). The colour of the
strip was analysed within 5 seconds of contact with the bacteria to determine if the
cytochrome c oxidase enzyme was produced (Thermo Fisher Scientific Inc., 2018). A deep
blue or violet colour change was an indication that the bacteria were oxidase positive.
Conversely, no colour change to the strip demonstrated that the bacteria were oxidase
negative and likely from the Enterobacteriaceae family (Thermo Fisher Scientific Inc., 2018).

3.2.3 (iii) Purity Plate
One isolated colony was picked from the TSA plate with a sterile loop, emulsified in 2.5 mL
of a sterile saline solution and then mixed to prepare a homogenous suspension. A purity
plate was made for each isolate with 100 µL of the bacterial suspension plated on nutrient
agar (NA) (Edwards Group Pty Ltd, Narellan, NSW). The purity plates were incubated at
37°C for between 18 and 24 hours.

3.2.3 (iv) Glycerol Stocks
To allow storage of the organism at -80°C a heavy suspension of the bacteria from each
purity plate was made in 800 µL LB broth, and 200 µL sterile glycerol was then added to the
solution. The solution was labelled with the identifying number given to the bacterial isolate
and the date of isolation and frozen at -18°C before being moved to -80°C storage.

3.2.3 (v) Identification to Species Level
Bacterial isolates identified as Gram negative and oxidase negative were initially tested with
the Microbact 12A Biochemical Identification Kit a strip of 12 substrates used for identifying
Enterobacteriaceae (ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) (Appendix A).
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The microbial identify of the bacteria was then confirmed by Matrix Assisted Laser
Desorption Ionization-Time of Flight (MALDI-TOF). The glycerol stocks containing the
organisms were transported on ice to a research laboratory for microbial identification
(Research Laboratory, 2nd Floor, J Block, QEII Medical Centre, Monash Avenue, Nedlands,
Western Australia). The laboratory identified the organisms with a MALDI Biotyper which
utilises MALDI-TOF (Bruker Daltonik, Bremen, Germany). The MALDI Biotyper CA System
Software generates a spectrum for the tested organism which is then transformed into a
peak list. This peak list is then compared to a database which contains peak lists for
reference organisms (Bruker Daltonics Inc., 2018). The best match microbial identification is
presented with a score which is used to interpret the reliability of the result (Table 8) (Bruker
Daltonics Inc., 2018).
Table 8. MALDI-TOF score value interpretation. Source: Bruker Daltonics Inc. (2018)
Score Value Range

Interpretation

2.00 - 3.00

High confidence with the result

1.70 - 1.99

Low confidence with the result

< 1.70

No organism identification is possible

3.2.4 Disc Diffusion Antibiotic Resistance Testing
Isolates identified as Gram negative bacteria were analysed for antibiotic susceptibility to
eight selected antibiotics using the disc diffusion method in accordance with the Disc
Diffusion Method for Antimicrobial Susceptibility Testing manual published by the European
Committee on Antimicrobial Susceptibility Testing (EUCAST, 2017). A maximum of two
different isolates from each fish sample were tested.

3.2.4 (i) Antibiotic Discs
The disc diffusion test was conducted with eight commercially available antibiotic discs
(ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) with the following concentrations:
ampicillin (10 μg), trimethoprim (5 μg), cefalotin (30 μg), cefalexin (30 μg), tetracycline (30
μg), nalidixic acid (30 μg), sulfonamides (300 μg) and streptomycin (10 μg). The antibiotics
selected were identified in previous studies as types commonly used in aquaculture or types
that bacteria isolated from aquatic sources frequently showed resistance toward (Akinbowale
et al., 2006; Akinbowale et al., 2007; Boss et al., 2016; He et al., 2016; Kang et al., 2016;
Kathleen et al., 2016; Pham et al., 2015; Ryu et al., 2012; Sudha et al., 2012; Yang et al.,
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2015; Zhang, Ying, Su, Zhou, & Liu, 2013). Furthermore, all antibiotics used in this study are
deemed as critically or highly important antimicrobials for human medicine by the WHO
(Table 9) (WHO, 2017a).
Table 9. Antibiotic types used for the disc diffusion test and their importance classification for
human medicine determined by the WHO.

Antimicrobial Class

Drug

Importance Classification

Aminoglycosides

Streptomycin

Critically important

Penicillins

Ampicillin

Critically important

Quinolones

Nalidixic acid

Critically important

Tetracyclines

Tetracycline

Highly important

Sulfonamides

Sulfonamides

Highly important

Cephalosporins

Cefalotin

Highly important

Cephalosporins

Cefalexin

Highly important

Sulfonamides

Trimethoprim

Highly important

Note. Adapted from the WHO (2017a).

3.2.4 (ii) Preparation of Inoculum and Inoculation of Agar Plates
A suspension of bacteria in 0.85% sodium chloride was prepared to the same density as a
McFarland 0.5 turbidity standard (EUCAST, 2017). Saline was used to adjust the density of
the organism suspension, which was compared visually to a Remel McFarland Equivalence
Turbidity Standard 0.5 (ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) against a
white background with black lines (EUCAST, 2017). The organism suspension was used for
inoculation within 60 minutes of preparation.

Prior to inoculation, the Mueller-Hinton agar (MHA) plates (Edwards Group Pty Ltd, Narellan,
NSW) were brought to room temperature and inspected to ensure that they were dry before
being used to test the antimicrobial susceptibility of the bacterial isolates (EUCAST, 2017). A

27

sterile cotton swab was dipped into the prepared suspension and the inoculum was applied
to the MHA to produce a lawn culture (EUCAST, 2017).

3.2.4 (iii) Application of Antimicrobial Discs
The antibiotic discs were stored at 4°C in a sealed container and were brought to room
temperature before use (EUCAST, 2017). Each organism was inoculated onto one and a
half MHA plates. Within 15 minutes of inoculation, sterile forceps were used to manually
apply six antibiotic discs to the whole plate: ampicillin (10 μg), cefalotin (30 μg), cefalexin (30
μg), tetracycline (30 μg), nalidixic acid (30 μg) and streptomycin (10 μg). Sulfonamides (300
μg) and trimethoprim (5 μg) were applied manually with forceps to the half plate (two isolates
per plate with a well-defined clear space between isolates). Within 15 minutes of the discs
being applied, the plates were inverted and incubated for between 16 and 20 hours at 37°C
(EUCAST, 2017).

3.2.4 (iv) Examination of Plates After Incubation
The plates were examined to confirm that they had been correctly inoculated, all plates
demonstrated a confluent lawn of growth which was evenly distributed across the surface
with circular and uniform inhibition zones (EUCAST, 2017). The inhibition zone was judged
visually from the back of the plate over a black surface and the zone edge was measured
with Vernier callipers. The EUCAST (2017) define the zone edge as the closest position on
the plate where bacterial growth is completely inhibited, when viewed from a distance of
30cm with the naked eye (Figure 5).

Zone diameter interpretive standards provided by the EUCAST (2018a) and the Clinical and
Laboratory Standards Institute (CLSI, 2018a; CLSI, 2018b) were used to classify the
bacteria as susceptible, intermediate or resistant to the tested antibiotics (Table 10).
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Figure 5. Disc diffusion test results on MHA demonstrating a clear zone of inhibition around
the six antibiotic discs (left image) and no zone of inhibition surrounding the four antibiotic
discs at the top of the plate (right image).

Table 10. Zone Diameter Interpretive Criteria (mm) for Enterobacteriaceae

Antimicrobial Agent

Zone Diameter Breakpoint (nearest whole mm)
Susceptible

Intermediate

Source

Resistant

Ampicillin (10μg)

≥ 14

N/A

< 14

EUCAST (2018a)

Cefalexin (30μg)

≥ 14

N/A

< 14

EUCAST (2018a)

Cefalotin (30μg)

≥ 18

15 - 17

≤ 14

CLSI (2018a)

Nalidixic Acid (30μg)

≥ 19

14 - 18

≤ 13

CLSI (2018b)

Streptomycin (10μg)

≥ 15

12 - 14

≤ 11

CLSI (2018b)

Sulfonamides (300μg)

≥ 17

13 - 16

≤ 12

CLSI (2018b)

Tetracyline (30μg)

≥ 15

12 - 14

≤ 11

CLSI (2018b)

Trimethoprim (5μg)

≥ 18

15 - 17

< 15

EUCAST (2018a)

Note. Adapted from CLSI (2018a); CLSI (2018b); EUCAST (2018a).
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3.2.5 Quality Control Tests
Escherichia coli ATCC 25922 (E. coli ATCC 25922), Pseudomonas aeruginosa (P.
aeruginosa ATCC 27853) and Staphylococcus epidermis (S. epidermis ATCC 12228) were
used as quality control organisms to monitor the effectiveness of the identification tests and
the antimicrobial sensitivity. E. coli ATCC 25922, S. epidermis ATCC 12228 and P.
aeruginosa ATCC 27853 were subcultured onto non-selective media, TSA or NA, before
being incubated overnight at 37°C (EUCAST, 2017).

3.2.5 (i) Gram Stain
Control smears were prepared using E. coli ATCC 25922 and S. epidermis ATCC 12228 as
the Gram negative and positive controls respectively. The control slides were stained in
accordance with the standard procedure before they were viewed under the oil immersion
lens (x100, total magnification x1000) on an Olympus CH30 microscope. The staining
procedure was determined as satisfactory if the S. epidermis on the positive control slide
stained purple and the E. coli on the negative control slide stained pink (Becton Dickinson
Pty Ltd., 2017; National Center for Biotechnology Information, n. d.).

3.2.5 (ii) Oxidase Testing
Each day that oxidase tests were performed, quality control tests were completed using P.
aeruginosa ATCC 27853 as the positive control organism and E. coli ATCC 25922 as the
negative control organism. The oxidase strips were deemed accurate if P. aeruginosa ATCC
27853 caused a deep blue or violet colour change to the oxidase strip within five seconds,
and no colour change occurred within five seconds after contact with E. coli ATCC 25922
(Hardy Diagnostics, 1996).

3.2.5 (iii) Disc Diffusion
Quality control for disc diffusion was conducted each week of testing using E. coli ATCC
25922, a recommended organism for quality control which demonstrates susceptibility to
antibiotics (CLSI, 2018b; EUCAST, 2017). A single colony from a freshly subcultured culture
was used to prepare a suspension for testing on MHA as described above. The newest test
result was compared to the target range, as determined by the CLSI or the EUCAST (Table
11) (CLSI, 2018b; EUCAST, 2018b). There was not any expected quality control range listed
for the inhibition zone of E. coli ATCC 25922 with sulfonamides. To ensure consistency the
zone diameter was recorded each week for this antibiotic and compared to previous results
to analyse for any trends or deviations.
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Table 11. Inhibition Zone Diameter Interpretive Criteria (mm) for quality control strain E. coli
ATCC 25922.

Antimicrobial Agent

Inhibition Zone Diameter

Source

(nearest whole mm)
Acceptable Range
Ampicillin (10μg)

15 - 22

EUCAST (2018b)

Cefalexin (30μg)

15 - 21

EUCAST (2018b)

Cefalotin (30μg)

15 - 21

CLSI (2018b)

Nalidixic Acid (30μg)

22 - 28

CLSI (2018b)

Streptomycin (10μg)

12 - 20

CLSI (2018b)

Not provided

Not provided

Tetracyline (30μg)

18 - 25

CLSI (2018b)

Trimethoprim (5μg)

21 - 28

EUCAST (2018b)

Sulfonamides (300μg)

Note. Adapted from CLSI (2018b); EUCAST (2018b)

3.3 Clostridium difficile in Fish
Fifty grams of the frozen fish portions were transported on ice to a research laboratory and
analysed for the presence of Clostridium difficile (Research Laboratory, 2nd Floor, J Block,
QEII Medical Centre, Monash Avenue, Nedlands, Western Australia). Selective enrichment
culture, polymerase chain reaction (PCR) toxin profiling and ribotyping methods were
performed to analyse the fish samples for the presence of C. difficile (Lim, Foster, Elliott, &
Riley, 2018).

4.0 Results

4.1 Data Analysis
Results were stored and analysed in Microsoft Excel (Microsoft, Washington, United States).
Statistical analysis was conducted using SPSS statistics software, version 25 (IBM
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Corporation, New York, United States). The significance level for each hypothesis test was
set at 5%.
4.2 Antibiotic Residues in Seafood
Two hundred and fifty-three seafood samples, a mix of fish (n = 176) molluscs (n = 45) and
crustacea (n = 32) were analysed for the presence of antibiotic residues (Figure 6). The
seafood products were from 22 countries. The largest portion of the samples were Australian
products. The imported products were predominately from Vietnam, Thailand, New Zealand,
Indonesia and China (Figure 6). Except for Thailand, these are the same countries that the
fish in the antibiotic resistance testing conducted in this study were imported from (Section
4.3.4).

Mollusc
13%

Other
19%

Crustacea
18%

China
4%

Australia
43%

Indonesia
4%

Fish
69%

New
Zealand
6%
Thailand
9%

Vietnam
15%

Figure 6. The portion of seafood (n = 253) categorised by fish, mollusc or crustacea (left)
and country of origin (right).

The results found high levels of compliance; the absence of antibiotic residues was observed
in 99.6% (n = 252) of the seafood samples. One sample analysed was noncompliant, with
erythromycin detected in excess of 0.01mg/kg in seafood sticks from Thailand. The
proportion of samples with antibiotic residues differs from the proportion of samples without
antibiotic resides (binomial test, p = 0.001).
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4.3 Antibiotic Resistant Bacteria from Fish
4.3.1 Method Validation
A series of validation tests were conducted on three occasions to ensuring that the standard
homogenisation process with fish did not impact on the bacterial count. An E. coli inoculum
was prepared by dislodging half a single colony of E. coli ATCC 25922 in a 5 mL container
with 2.5 mL LB broth. Following an incubation period for 60 minutes at 37°C (to allow
logarithmic growth to begin), 100 µL of the E. coli inoculum was transferred with a sterile
pipette into three separate containers (A, B and C) described below.

Solution A: 100 µL of the E. coli inoculum and 50 g of LB broth. The contents were mixed
manually with a pipette and were not homogenised.
Solution B: 100 µL of the E. coli inoculum and 50 g of LB broth. The contents were
homogenised using the homogenisation method described in section 3.2.2
Solution C: 100 µL of the E. coli inoculum, 45 g of LB broth and 5 g of Basa, homogenised
as previously described. The fish had been cooked in a frying pan prior to use to eliminate
any viable organisms.
Ten-fold serial dilutions were made up to a final dilution of 10-6 for each of the three solutions
(A, B and C) by mixing 100 µL of the solution with 900 µL of LB broth. The dilutions were
plated on NA in three 10 µL spots and incubated for 24 hours at 37°C.

The tests were repeated three times and the log10 CFU/mL were calculated for each solution
(Figure 7). There was no significant difference between the result for the three solutions (p=
0.666). This demonstrates that there was no bacterial loss due to the homogenisation
process used. Furthermore, the introduction of fish to the solution did not reduce the
bacterial count, demonstrating that there were unlikely to be inhibitors of microbial growth
present in the fish flesh.
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Figure 7. Results of the blender validation tests. Note. Solution contents: Solution A (E. coli
and LB broth, manually mixed), Solution B (E. coli and LB broth, homogenised), Solution C
(E. coli, LB broth and Basa, homogenised)

4.3.2 Microbial Growth Results
Thirteen of the 44 fish products (29%) did not demonstrate bacterial growth on the MAC agar
dilution plates after 48 hours incubation (Appendix B). The MCFU/g were calculated for the
31 products with bacterial growth (Appendix B). Thirty-eight of the samples (86%) had
bacterial growth of less than 10³ MCFU/g, the median value 4 × 10² MCFU/g is within this
range. Of the products with bacterial growth, the lowest observed value was 102 MCFU/g
and the highest observed value was 6.6 × 105 units. Overall the negative binomial
regression test found there is no significant association between the country of origin
category (Australian, n=21, vs imports, n=23) and the MCFU/g result (p=0.161).

4.3.3 Microbial Identification
Preliminary identification tests were conducted on 88 bacterial isolates with a focus on
obtaining Gram negative isolates. Further tests were not conducted on isolates deemed to
be Gram positive. Thirty-five presumptive Enterobacteriaceae isolates (n=35) were identified
to species level by MALDI-TOF. The score values of the MALDI-TOF microbial identification
all exceeded 2.0 (between 2.05 and 2.619) which demonstrates a high level of accuracy and
confidence with the result (Appendix B).
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The bacterial species (n=15) identified are from ten different genera of six different families
(Figure 8 and Figure 9).

Rhizobium , 1
Pseudomonas , 1

Stenotrophomonas, 2

Aeromonas , 3
Buttiauxella , 4

Pantoea, 1

Acinetobacter,
10

Pluralibacter, 1

Serratia, 10
Yersinia , 2

Figure 8. The number of Gram negative bacteria (n=35) identified by genus (colour
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categorisation by family classification).
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Figure 9. The number of Gram negative bacteria (n=35) identified by species (colour
categorisation by genus).

35

1

4.3.4 Fish Details
The 35 bacterial isolates identified by MALDI-TOF were obtained from 28 different fish
products. Seven fish samples (25%) provided two different bacterial species for analysis,
with the remaining bacterial isolates obtained from individual fish samples. More than half of
the products provided the fish’s scientific name accompanying the common fish name on the
label. Scientific names which were not listed on Australian fish products were established in
accordance with the WA Government’s fish identification guide (Department of Fisheries,
2017). FishBase, a global database for fish species was utilised to identify the other scientific
fish names (Froese & Pauly, 2018). The 28 fish products were from 15 different fish genera,
the dominant fish genera were Pangasius (25%) (Table 12). Of the 28 fish which provided
bacterial isolates, more than half (63%) originated from Australia and 37% (n=13) were
imports from either Vietnam, Indonesia, China or New Zealand (Figure 10).

Figure 10. The country of origin of the fish from which isolates were obtained. The number
of fish in each country category is indicated to the right of the country marker. Note. Adapted
from Google (2018).
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Seven percent of the fish products were labelled as farmed and 14% were labelled as wild
caught (Table 12). The majority (79%) of fish products were not labelled either wild caught or
farmed. The fish products with missing labelling information were assumed to be farm
produced if they were identified as common aquaculture species (Table 12). It is estimated
that 46% of the fish products may have been farm produced. This assumption is in line with
expectations by the FAO (2016) that approximately half of the fish consumed around the
globe is produced by aquaculture.

Table 12. Details of the fish products (n = 28) which the bacteria (n = 35) were isolated from.
Fish (scientific name)

No.
products

Country of
origin

Labelling
(Wild/
Farmed)

Aquaculture
Species

Reference

Mo et al. (2015)

Ctenopharyngodon idella

1

China

Not specified

Diagramma labiosum

1

Australia

Not specified

Epinephelus multinotatus

1

Australia

Not specified

Gymnocranius grandoculis

1

Australia

Not specified

Lethrinus nebulosus

1

Australia

Not specified








Lethrinus punctulatus

2

Australia

Wild (n = 1)

Lutjanus erythropterus

2

Australia

Wild (n = 1)



Lutjanus lemniscatus

1

Indonesia

Not specified



Lutjanus malabaricus

1

Australia

Not specified



Lutjanus russellii

1

Australia

Not specified

Macruronus novaezelandiae

1

New
Zealand

Wild (n = 1)

Mugil cephalus

1

Australia

Not specified

Nemipterus furcosus

1

Australia

Not specified

Neoarius midgleyi

1

Australia

Not specified

Ophiocephalus striatus

1

Vietnam

Not specified

Pangasius hypophthalmus

Pristipomoides multidens

7

1

Vietnam

Australia
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Farmed
(n = 2)
Not specified










Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Cheng, Ma,
Yang, Hassan,
and Qin (2018)
FAO (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Froese and
Pauly (2018)
Pham et al.
(2015)
Pham et al.
(2015)
Froese and
Pauly (2018)

FAO (2018)

1

Indonesia

Not specified

1

Australia

Wild (n = 1)


N/A

Pseudocaranx georgianus
Seriola lalandi

1

Australia


Froese and
Pauly (2018)



Not specified

Legend:  = yes,  = no, N/A = not applicable.

4.3.5 Antibiotic Resistance Patterns
As expected, susceptibility patterns were different between the ten bacterial genera (Table
13) (Kruskall-Wallis Test, p=0.002). All the isolates were susceptible to tetracycline and
sulfonamides and the resistance to other antibiotics was varied based on the CLSI and the
EUCAST measurement guidelines for the inhibition zone (Appendix C). Majority of the
observed resistance was expected for the bacterial species or was similar to previous
reports (Table 12). Potential acquired antibiotic resistance was observed in four
Acinetobacter species and a Rhizobium isolate (Table 14).

Table 13. The number of isolates in each bacterial genera resistant to antibiotics in purple
font with antibiotic resistance which is not commonly reported and may potenially be
acquired in bold and underlined. The number in parentheses in orange font represents the
number of isolates with intermediate susceptibility.

Bacterial Genera AMP

CXN

CEF

NA

S

TMP

SUL

TE

Acinetobacter (n=10) 2

7

10

1

2

10

0

0

Serratia (n=10) 3

5

10

0

0

0

0

0

Buttiauxella (n=4) 0

0

1 (3)

0

0

0

0

0

Aeromonas (n=3) 3

0

2

0

0 (2)

0 (1)

0

0

Yersinia (n=2) 1

0

1 (1)

0

0

0

0

0

Stenotrophomonas (n=2) 1

2

2

0

1

2

0

0

Pseudomonas (n=1) 1

1

1

0

0

0

0

0

Rhizobium (n=1) 1

0

1

0

1

1

0

0

Pantoea (n=1) 0

0

0

0

0

0

0

0

Pluralibacter (n=1) 0

0

0

0

0

0

0

0

Legend: AMP = ampicillin, CXN = cefalexin, CEF = cefalotin, NA = nalidixic acid,
S = streptomycin, TMP = trimethoprim, SUL = sulfonamides, TE = tetracyline.
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Table 14. Bacterial isolates with potential acquired antibiotic resistance.
Fish Details
Bacterial Species

Acinetobacter

Antibiotic Type/s

Ampicillin

haemolyticus

Scientific Name

Lutjanus

Ampicillin and

Pangasius

haemolyticus

streptomycin

hypophthalmus

Acinetobacter

Nalidixic acid

Ophiocephalus

ursingii

Origin

Wild*

Australia

Farmed

Vietnam

Farmed

Vietnam

Farmed

Vietnam

Farmed

China

Farmed

striatus
Streptomycin

haemolyticus
Rhizobium

Farmed or

erythropterus

Acinetobacter

Acinetobacter

Country of

Pangasius
hypophthalmus

Trimethoprim

radiobacter

Ctenopharyngodon
idella

*Source: Cheng et al. (2018); Mo et al. (2015); Pham et al. (2015)

4.3.6 Country of Origin
Of the ten bacterial genera identified, Serratia and Acinetobacter were the two genera which
contained bacterial isolates obtained from a mix of Australian and imported fish (Table 15).
The Acinetobacter strains were isolated from fish samples which originated from Australia (n
= 3) and overseas (Indonesia, n = 1 and Vietnam, n = 6). The Serratia strains were isolated
from fish which originated from Australia (n = 8) and overseas (New Zealand, n = 1 and
Vietnam, n= 1).
Table 15. Acinetobacter and Serratia isolates resistant to antibiotic types, categorised by the
origin of the fish.

Bacterial Genera

Acinetobacter

Antibiotic resistance

Australian (n)

Imported (n)

Cefalotin

3 (3)

7 (7)

Trimethoprim

3 (3)

7 (7)

Cefalexin

3 (3)

4 (6)

Ampicillin

1 (3)

1 (7)

Streptomycin

0 (3)

2 (7)
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Serratia

Nalidixic Acid

0 (3)

1 (7)

Cefalotin

8 (8)

2 (2)

Ampicillin

3 (8)

0 (2)

Cefalexin

4 (7)

1 (2)

4.3.7 Quality Control: Standard Antimicrobial Test
The disc diffusion test was performed on eight occasions for quality control (Appendix D).
The zone diameter results were always consistent with the target range for E. coli ATCC
25922 as determined by available ranges provided by the EUCAST and CLSI. Although
there is no available target range for sulfonamides, all results were consistent and within
3mm of each other. The overall finding validated the performance of the disc diffusion
method, the results obtained, and the quality of the materials used.

4.4 Clostridium difficile in Fish
C. difficile was not detected in the 44 fish samples (Appendix B).

5.0 Discussion

5.1 Antibiotic Residues in Seafood
5.1.1 Seafood Sold in Australia
This study determined the concentration of the eight antibiotics tested for were below the
LOR in 99.6% (n = 252) of the Australian sold seafood samples. All the seafood samples
originating from Australia were compliant. One imported sample contravened the ANZFSC
with the detection of erythromycin in seafood sticks originating from Thailand. The country of
origin of the seafood with the non-compliant antibiotic residue result is unsurprising. The use
of erythromycin in Thailand aquaculture has been previously reported (Rico et al., 2012).

The high levels of compliance observed in the domestic seafood products analysed in our
study are in line with findings from the Australian Government’s 2016-17 National Residue
Survey which found 99% of Australian domestic fish samples did not contain veterinary
medicine residues (DAWR, 2017a). The testing protocol in the National Residue survey
differs per product type. For example, Australian barramundi raised in aquaculture settings
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are tested for residues of 52 antibiotics including amoxicillin, ampicillin, oxytetracycline,
sulfamethoxazole and trimethoprim (DAWR, 2017b). Compliance rates with Australian
legislation observed in the National Residue Survey have remained consistently high over
the past four years. The 2014-15 survey and the 2015-16 survey both found 100% of
Australian aquaculture and wild caught seafood samples were free from antibiotic residue
contamination (DAWR, 2017a).

However, it is an unexpected result that there was only one non-compliant result from the
seafood samples imported into Australia. The AQIS survey conducted in 2006 and 2007
found quantifiable levels of antibiotic residues in 31% of imported seafood (n = 100) from
Asian countries and New Zealand (Australian Quarantine and Inspection Service, 2008).
Ampicillin was detected in three fish samples in concentrations ranging from 10 - 130 µg/kg
and amoxicillin was detected in 11 fish and crab samples at a concentration between 14 380 µg/kg. In contrast, our study did not find any seafood containing amoxicillin or ampicillin
in excess of 20 µg/kg and 30 µg/kg, respectively. It is important to note that the AQIS survey
analysed seafood for a broader range of antibiotics (n = 40) in comparison to the current
study (n = 8). As a result, the AQIS survey detected increased non-compliant results with
residues of eight antibiotic types that our study did not analyse for. Furthermore, it is
possible that the AQIS found significantly higher levels of non-compliance due to a lower
LOR in the testing laboratory. For instance, AQIS detected oxytetracycline (2 - 8.6 µg/kg)
and sulfamethoxazole (2.3 - 5.4 µg/kg) in concentrations which were below the lower LOR
applied in our study (20 µg/kg). Nevertheless, based on the antibiotic types which can be
compared, our finding suggests imported seafood has improved compliance with Australian
food legislation as compared to 2006.

5.1.2 Country of Origin
The concentration of eight antibiotics were below the LOR in 99.6% (n = 252) of the seafood
samples. One sample from Thailand contained traces of one antibiotic. The overall high
levels of compliance in this study suggest that country of origin does not seem to correlate
with the presence of antibiotic residues in food sold in Australia.

This result is surprising since antibiotic use is excessive and frequent in Asian aquaculture
(Pruden et al., 2013; Rico et al., 2012). As a result, antibiotic residue contamination has
been found in seafood obtained in China, Vietnam, Thailand and South Korea (Jansomboon
et al., 2016; Kang et al., 2018; Song et al., 2017; Uchida et al., 2016). It is possible there are
different production standards in Asian aquaculture, influenced by whether the prospective
buyer is domestically or internationally located (Uchida et al., 2016). Fish farmers intending
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to export products to developed countries are forced to comply with regulated veterinary
residue limit requirements and stringent border testing procedures, or they risk jeopardizing
their businesses (Pham et al., 2015). In contrast, Asian farmed seafood intended for
domestic sale are at a risk of containing increased levels of antibiotic residues since there is
less stringent legislation and limited government testing to control the presence of antibiotics
in food locally (Henriksson et al., 2018; Zellweger et al., 2017). Shrimp farmed in Thailand
that is intended for export overseas and fails internal tests for antibiotic residue
contamination is sold to the Thai domestic market (Holmström et al., 2003).

5.1.3 Health Risk (Adverse Drug Reaction) within Australia
The one non-compliant result detected in seafood sticks from Thailand contained
erythromycin in a concentration of 10 µg/kg. Oral exposure to erythromycin may cause
ototoxicity or peripheral neuritis, however, the concentration of erythromycin detected in this
study would not cause a risk of adverse drug reaction to the consumer (Codex Alimentarius
Commission, 2017; Liu et al., 2017). The maximum ADI of erythromycin stipulated by the
Codex Alimentarius Commission was 0.7 µg/kg body weight, which equates to 60.2 µg per
day for the average Australian male, weighing 86 kg, and 49.8 µg per day for the average
Australian woman, weighing 71.1 kg (Australian Bureau of Statistics, 2013; Codex
Alimentarius Commission, 2017). Therefore, the concentration of erythromycin detected in
this study does not pose an immediate health risk to the average Australian adult. A person
would have to consume approximately 5 - 6 kg of contaminated fish sticks a day to exceed
the safe ADI, which is unlikely. In contrast to our finding, a study in China detected
erythromycin in shrimp samples at a concentration of up to 15,090 µg/kg, which exceeds the
Codex Alimentarius Commission’s MRL and safe daily limit for the average person, risking
harm to the consumer (Chen et al., 2015).

Although a direct risk to consumer health from antibiotic residues was not demonstrated,
there is still a potential risk to the health of the Australian consumer in two ways. Firstly,
seafood sold in Australia may be contaminated with antibiotic types that were evaluated in
this study. There are numerous other antibiotics which have been identified as being used in
overseas aquaculture resulting in pollution of the aquatic environment and aquatic
organisms (Kang et al., 2018; Zhong et al., 2018). Secondly, our study was not able to
confirm that the aquatic organisms were produced in an antibiotic free environment.
Antibiotic residues are not likely to remain in the animal’s edible tissue if the farmer waits the
withdrawal time prescribed by the drug manufacturer prior to harvesting the animal for
human consumption (Okocha et al., 2018). For instance, a recent study determined that
prawns orally dosed with antibiotics have a minimal chance of the drug remaining in the
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body tissue following a withdrawal period of three weeks (Sun et al., 2016). It is therefore
possible that the seafood sold in Australia was previously exposed to antibiotics. Antibiotic
resistance studies on bacteria isolated from aquatic animals is the best method to assess
the level of risk posed to the consumers’ health via this pathway.

5.2 Antibiotic Resistance in Bacteria Isolated from Fish
The range of bacteria identified in our study, 15 species from ten genera, is not unusual
since aquatic organisms are known to contain multiple bacterial genera, attained from their
surrounding aquatic environment (Novoslavskij et al., 2016). The ten bacterial genera
identified in this study, Acinetobacter, Serratia, Buttiauxella, Aeromonas, Stenotrophomonas,
Yersinia, Pantoea, Pluralibacter, Pseudomonas and Rhizobium, are not the typical strains
analysed in antimicrobial susceptibility studies which often focus on common foodborne
pathogens found on fish such as E. coli, Vibrio and Salmonella (Elbashir et al., 2018; He et
al., 2016; Kang et al., 2016; Ryu et al., 2012; Yang et al., 2015; Zhang et al., 2013). It is
surprising that Vibrio were not identified in our study since a higher prevalence of Vibrio has
previously been detected in fish samples (45.1%) and seafood samples (92%) (Sudha et al.,
2012; Woodring et al., 2012). The absence of other pathogenic Enterobacteriaceae is typical
since they are less commonly reported on seafood, for example a previous study found 6.7%
of seafood samples were contaminated with E. coli (Ryu et al., 2012; Yang et al., 2015). The
most common bacteria identified in our study were Acinetobacter spp. (28.6%) and Serratia
spp. (28.6%). In comparison, a previous study on bacteria isolated from seafood found 13%
were Serratia and Acinetobacter made up less than 5% of the total isolates from seafood
(Noor Uddin et al., 2013).

All 15 identified bacterial species were Gram negative, which are ubiquitous in the
environment and have varied potential pathogenicity to humans (Table 16).

Table 16. Characteristics by bacterial genera.

43

Habitat

Pathogenicity

Soil or

Potential

Foodborne

Wound

Hospital

Water

Human

Infection

Infection

acquired

(Community

infection

Pathogen

Reference

acquired)
Acinetobacter
(A. haemolyticus, A.











Maravić et al.











Janda and











Brooke (2012)



a





a

(2016).

junii and A. ursingii)

Aeromonas
(A. hydrophila and

Abbott (2010)

A. salmonicida)

Stenotrophomonas
(S. maltophilia)

Rhizobium
(R. radiobacter),

Mihaylova,
Genov, and
Moore (2014)

Serratia
(S. liquefaciens and











Mahlen



a







Novoslavskij



a





a

(2011)

S. fonticola)

Yersinia
(Y. kristensenii, and

et al. (2016)

Y. intermedia)

Pseudomonas
(P. alcaligenes)

Xu, Zeng,
Jiang, Zhou,
and Zeng
(2015)

Buttiauxella
(B. agrestis)
Pantoea
(P. agglomerans)



a



a





a



a

a

Antonello et
al. (2014)
Saticioglu,
Duman, and
Altun (2018)



Pluralibacter
(P. gergoviae)

Legend:  = yes,  = no,

a



a



= rarely reported or limited information is available,
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a

Whitman
(2015)

5.2.1 Acinetobacter species
Acinetobacter spp. are often found in wet habitats including ponds, fish farms and seawater
and sewerage (Wong et al., 2017). Acinetobacter spp. are generally opportunistic pathogens
which cause nosocomial infections which are often transmitted in intensive care facilities
(Gillespie & Hawkey, 2006). The three species identified in this study, A. haemolyticus (n=8),
A. junii (n=1) and A. ursingii (n=1), are potential human pathogens (Maravić et al., 2016).
The most clinically significant species of Acinetobacter, A. baumanii, was not identified.

The susceptibility results obtained in this study must be read with caution. There are limited
breakpoint guidelines for Acinetobacter spp. and seven of the antibiotics tested do not have
established breakpoints meaning that they are not commonly used clinically to control
infections caused by this species. Tetracycline, the sole antibiotic from this study with
guidelines for Acinetobacter spp., has the same diameter interpretive criteria as outlined for
Enterobacteriaceae (CLSI, 2018b). The susceptibility results for Acinetobacter spp. with the
antibiotics which do not have breakpoints were interpreted based on CLSI and EUCAST
breakpoints for Enterobacteriaceae (CLSI, 2018b; EUCAST, 2018a).

In this study, antibiotic resistance was commonly demonstrated among Acinetobacter spp.,
with all isolates (n=10) resistant to at least two antibiotics. Resistance was observed to
cefalotin (100%), cefalexin (70%), trimethoprim (100%), nalidixic acid (10%), ampicillin
(20%) and streptomycin (20%). This finding is in line with expectations for this genus which
is often highly resistant to many antibiotics, due to acquired and intrinsic resistance
mechanisms (Richard & Yitzhak, 2014). Acinetobacter spp. have the capacity to rapidly
develop antibiotic resistance by acquiring resistant genes obtained from mobile genetic
elements transferred from other bacterial species (Walker, 2007). Environmental strains of
Acinetobacter spp. are significant reservoirs of antibiotic resistance in the environment and
evaluation of these strains may provide evidence for increasing antibiotic resistance (Wong
et al., 2017).
Cefalotin: High levels of resistance in Acinetobacter to cephalosporins is to be expected
since rates of resistance to first generation cephalosporins, such as cefalexin and cefalotin,
have been rising since the 1970’s (Vikas, Sinha, & Singh, 2010). The resistance to cefalotin
(100%) identified by this study has slightly increased in comparison to the results from a
study in 1971 conducted in the US which found that 77% of clinical strains of A.
haemolyticus (n=38) were resistant to cefalotin (Gilardi, 1971). More recently, a French
study found clinical isolates of A. ursingii were all resistant to cefalotin (Dortet, Legrand,
Soussy, & Cattoir, 2006).
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Trimethoprim: The resistance to trimethoprim (100%) is usual for Acinetobacter species. A
previous study in France similarly found 70% of clinical A. ursingii isolates were resistant to
trimethoprim, with the remaining 30% demonstrating intermediate susceptibly (Dortet et al.,
2006). Resistance in Acinetobacter spp. to trimethoprim has been attributed to efflux pumps
with acquisition via horizontal gene transfer (Van Looveren & Goossens, 2004).
Nalidixic acid, ampicillin and streptomycin: The resistance observed to nalidixic acid
(10%), ampicillin (20%) and streptomycin (20%) in this study is likely acquired. Nalidixic acid,
ampicillin and aminoglycosides, including streptomycin were used in the early 1970’s to
successfully resolve Acinetobacter infections (Dalla-Costa et al., 2003; Van Looveren &
Goossens, 2004). Since then, resistance has been rising to these antibiotic classes (Van
Looveren & Goossens, 2004). A. ursingii (n = 1) isolated from snakehead fish
(Ophiocephalus striatus) was resistant to nalidixic acid and A. haemolyticus (n = 2) isolated
from catfish (Pangasius hypophthalmus) were resistant to streptomycin. It is likely that these
fish from Vietnam were farm produced since catfish and snakehead are among the most
common fish species which are grown in aquaculture in Vietnam (Pham et al., 2015).
Streptomycin is used in Vietnamese aquaculture and nalidixic acid is a common antibiotic
used in the countries with the largest aquaculture production, inclusive of Vietnam (Done et
al., 2015; Rico et al., 2012).

Resistance to ampicillin was observed in two A. haemolyticus isolates, one from catfish
(Pangasius hypophthalmus) originating from Vietnam and the other from crimson snapper
(Lutjanus erythropterus) from Australia. Ampicillin is frequently used in Vietnamese
aquaculture including in the production of catfish (Pham et al., 2015; Rico et al., 2012). In
Vietnam, the use of ampicillin is permitted with limited use in aquaculture to treat disease
(Binh, Dang, Anh, Ky, & Thai, 2018). Crimson snapper is a significant fish species for
aquaculture in Australia and Asia (Cheng et al., 2018). Ampicillin is not permitted for use in
Australian aquaculture but is permitted for therapeutic use in Australian cattle and sheep
(APVMA, 2014). It is possible that the crimson snapper was exposed to contaminated
agricultural waste containing ampicillin residues or that ampicillin was used illegally to treat
disease in fish.

5.2.2 Aeromonas species
Aeromonas spp. are naturally found in brackish and fresh water, and soil (Bhatia, CastroBorobio, Greene, & Nanjappa, 2017). Accordingly, this species has previously been isolated
from the aquaculture environment, fish and invertebrates (Piotrowska & Popowska, 2014). A.
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hydrophila (n = 2) and A. salmonicida (n = 1), found in this study, cause disease in humans
and fish, respectively (Janda & Abbott, 2010). Although healthy populations are at risk of
infection from exposure, immunocompromised individuals are at a greater risk of developing
serious complications (Janda & Abbott, 2010). A broader range of health impacts have been
associated with this bacterium including wound infection, however, gastrointestinal illness is
the most common infection in humans (Clark & Chenoweth, 2003; Whitman, 2015).
Outbreaks of gastrointestinal illness have been caused by the ingestion of raw fish
contaminated with A. hydrophila (Praveen Kumar, Chanchal, Shashank, Nirupama, &
Subha, 2016)

The susceptibility results obtained in this study should be interpreted cautiously as seven of
the antibiotics tested do not have established breakpoints. Tetracycline is the sole antibiotic
from this study with established zone diameter guidelines for Aeromonas spp., including A.
hydrophila, where interpretive criteria are the same as Enterobacteriaceae (CLSI, 2010). Our
Aeromonas spp. were susceptible to tetracycline. Other antibiotic results were inferred using
interpretation criteria based on CLSI and EUCAST breakpoints for Enterobacteriaceae
(CLSI, 2018b; EUCAST, 2018a).
Ampicillin: All the Aeromonas spp. (n = 3) isolated in this study demonstrated resistance to
ampicillin. This is expected for Aeromonas spp. which are typically resistant to ampicillin and
penicillin (Bhatia et al., 2017; CLSI, 2010; Whitman, 2015). These data are comparable to
previous studies conducted on Aeromonas spp. isolated from seafood. Resistance to
ampicillin was found in 100% of Aeromonas isolates from fish in Malaysia (Radu, Ahmad,
Ling, & Reezal, 2003), 93.5% of Aeromonas isolates from catfish in Vietnam (Nguyen et al.,
2014), 86% of Aeromonas spp. isolated from fish in Australia (Akinbowale et al., 2006) and
89% of Aeromonas spp. isolated from seafood in Thailand (Woodring et al., 2012).
Cefalotin: This study found two Aeromonas isolates (A. hydrophila and A. salmonicida)
isolated from the same fish (Lethrinus punctulatus) demonstrated resistance to cefalotin. The
resistance to cefalotin is expected since many Aeromonas spp. are resistant to firstgeneration cephalosporins due to the production of enzymes that deactivate beta-lactam
antibiotics (Clark & Chenoweth, 2003; CLSI, 2010). Previous Australian studies found
between 46 and 85% of Aeromonas spp. isolated from fish were resistant to cefalotin
(Akinbowale et al., 2006; Akinbowale et al., 2007).
Streptomycin, trimethoprim, nalidixic acid and tetracycline: In this study, two
Aeromonas spp. had intermediate susceptibility to streptomycin and one Aeromonas isolate
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had intermediate susceptibility to trimethoprim. Compared to previous findings, this
demonstrates a reduction in antibiotic resistance. Streptomycin resistance was observed in
31% of Aeromonas isolates obtained from catfish in Vietnam (Nguyen et al., 2014).
Aeromonas isolates from a Turkish fish market were all found to demonstrate resistance
against trimethoprim (Praveen Kumar et al., 2016). Furthermore, our study found no
resistance in Aeromonas to nalidixic acid and tetracycline. This is an improved result
compared to previous studies in China and Vietnam which found resistance in Aeromonas
isolated from fish to nalidixic acid (52 - 73%) and tetracycline (34 - 89%) (Nguyen et al.,
2014; Yang et al., 2018). The variation in results is likely due to differences in how the fish
were produced. The Aeromonas in our study were isolated from fish species (Lutjanus
russellii and Lethrinus punctulatus) that are commonly wild caught off the coast in North
Western Australia, as opposed to the other studies which predominantly isolated Aeromonas
from catfish and grass carp, fish species that are commonly farmed Asia and are likely
exposed to antibiotics during production (Department of Fisheries, 2017; Pham et al., 2015)

5.2.3 Stenotrophomonas species.
Stenotrophomonas spp. are environmental bacteria and the species identified in this study,
S. maltophilia, has previously been isolated from a range of seafood (Abraham, Paul,
Adikesavalu, Patra, & Banerjee, 2016; Falagas, Kastoris, Vouloumanou, & Dimopoulos,
2009). S. maltophilia is an opportunistic human pathogen, immunocompromised individuals
are at the greatest risk of developing hospital-acquired infections and, less frequently,
community-acquired infections, including wound infection (Brooke, 2012; Falagas et al.,
2009). This organism can cause infection throughout the body, including in the lungs, blood,
eyes, urinary tract (UTI) and brain (Abraham et al., 2016).

EUCAST provide susceptibility breakpoint guidelines only for co-trimoxazole for
Stenotrophomonas spp. since it is the preferred antibiotic treatment for S. maltophilia
infections (Kim et al., 2018). The antimicrobial susceptibility results for S. maltophilia were
inferred using interpretation criteria based on CLSI and EUCAST breakpoints for
Enterobacteriaceae (CLSI, 2018b; EUCAST, 2018a). Therefore, the results for other agents
in this study must be interpreted carefully (Abbott, Slavin, Turnidge, Thursky, & Worth, 2011;
EUCAST, 2012).
Cefalotin, cefalexin, trimethoprim, streptomycin and ampicillin: The S. maltophilia
isolates (n=2) in this study were resistant to five antibiotics, cefalotin (100%), cefalexin
(100%), trimethoprim (100%), streptomycin (50%) and ampicillin (50%). This species is
known to demonstrate resistance to a broad range of antibiotics (Brooke, 2012; Falagas et
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al., 2009). The CLSI (2018b) standards state that S. maltophilia is intrinsically resistant to
cefalotin, cefalexin, trimethoprim, ampicillin, and the aminoglycoside class of antibiotics,
which includes streptomycin. Intrinsic antibiotic resistance in S. maltophilia can be attributed
to low membrane permeability, beta-lactamases, modifying enzymes and efflux pumps
(Abbott et al., 2011). S. maltophilia is also known to acquire antibiotic resistance from other
bacteria in the environment (Brooke, 2012).
Tetracycline: Against expectations, S. maltophilia in this study were susceptible to
tetracycline (CLSI, 2018b). This result is unsurprising for the S. maltophilia isolated from the
sweetlips snapper (Lutjanus lemniscatus) imported from Indonesia since this fish is not a
species commonly farmed in this location (FAO, 2018). The susceptibly to tetracycline
observed in the S. maltophilia isolated from catfish (Pangasius hypophthalmus) imported
from Vietnam is a surprise since this fish is one of the top farmed species in Vietnam and a
previous study found 29% of Vietnamese aquaculture farms used tetracycline in their
production (Nguyen Dang Giang et al., 2015).

5.2.4 Rhizobium species
Rhizobium spp. are present throughout the environment especially in soil and plants (Lai et
al., 2004; Sood, Nerurkar, & Malvankar, 2010). Rhizobium spp. are not often associated with
aquatic environments, suggesting soil contamination has occurred. Rhizobium radiobacter,
also known as Agrobacterium radiobacter, is a rare, opportunistic human pathogen which
causes hospital and community acquired disease, particularly in immunocompromised
people (Lai et al., 2004). Although R. radiobacter can cause bacteraemia, UTI and
pneumonia, it is considered of low medical importance since it is uncommon and has low
virulence (Mihaylova et al., 2014; Sood et al., 2010). Foreign objects introduced into the
body, often catheters, are regularly associated with R. radiobacter infection (Kaselitz,
Hariadi, Lipuma, & Weinberg, 2012; Sood et al., 2010).

There are limited standardised breakpoint guidelines for Rhizobium species. Therefore, the
antimicrobial susceptibility results for Rhizobium spp. were inferred using interpretation
criteria based on CLSI and EUCAST breakpoints for Enterobacteriaceae (CLSI, 2018b;
EUCAST, 2018a). Consequently, the susceptibility results obtained in this study must be
read with caution.
Cefalotin, ampicillin, streptomycin and trimethoprim: The R. radiobacter isolate in this
study (n=1) demonstrated resistance to cefalotin, ampicillin, streptomycin and trimethoprim.
The results are within expectations since there is often a wide variation in susceptibility
49

patterns to antibiotics between Rhizobium strains (Chen, Hansen, & Hansen, 2008). It is
suggested that R. radiobacter may develop resistance to multiple antibiotics from contact
with antibiotic producing organisms which are abundant in soil, where R. radiobacter often
resides (Sood et al., 2010). Consistent with our results, resistance in R. radiobacter to
cephalosporins and aminoglycoside antibiotics have been previously reported, this can
include streptomycin and cefalotin (Chen et al., 2008; Sood et al., 2010). The observed
resistance to trimethoprim has not previously been described, although it is of interest this
organism is usually susceptible to a combination of trimethoprim with sulfamethoxazole (also
known as co-trimoxazole) (Kaselitz et al., 2012; Sood et al., 2010). It is possible the
resistance was acquired from antibiotic exposure since trimethoprim is permitted for use in
the aquaculture industry in China and the R. radiobacter strain was isolated from a grass
carp (Ctenopharyngodon Idella), one of the most commonly farmed fish species in China
(Mo et al., 2015).

5.2.5 Serratia species
Serratia spp. are ubiquitous in the aquatic environment (Gillespie & Hawkey, 2006). Serratia
spp. are responsible for causing opportunistic and nosocomial infections in hospitalised
patients, mainly affecting immunocompromised patients (Traub, 2000). The two species of
Serratia identified in this study, S. liquefaciens and S. fonticola, are potential human
pathogens (Stock, Burak, Sherwood, Grüger, & Wiedemann, 2003). S. liquefaciens is the
second most common strain of Serratia responsible for human infection and has been
associated with bloodstream infection outbreaks in hospitals (Mahlen, 2011). In comparison,
the pathogenicity of S. fonticola is lesser known but it has been infrequently identified in
community acquired wound infection (Mahlen, 2011).
Cefalotin, cefalexin and ampicillin: Serratia spp. (n=10) were resistant to cefalotin (100%),
cefalexin (50%) and ampicillin (30%). This result is expected since Serratia species often
demonstrate intrinsic resistance to a number of beta-lactams including ampicillin and
cephalosporins (Mahlen, 2011). Consistent with our study findings, widespread resistance to
cefalotin is commonly reported (Whitman, 2015). Previous studies found that all Serratia
strains were resistant to cefalotin (Cooksey, Bannister, & Farrar, 1975; Freney et al., 1988;
Zabransky, Hall, Day, & Needham, 1969). Higher levels of resistance than observed in our
study were reported from the USA in 1969 when 100% of Serratia isolates (n = 15) were
resistant to cefalexin (Zabransky et al., 1969). Resistance to ampicillin was previously
reported in 42% of Serratia spp. isolated from fish and shrimp in Denmark (Noor Uddin et al.,
2013). In our study, resistance to ampicillin was only observed in S. fonticola and the S.
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liquefaciens strains were all susceptible, suggesting a likely difference in natural
susceptibility to ampicillin between different Serratia species.

5.2.6 Yersinia species
Yersinia spp. are ubiquitous in the environment (Verbikova, Borilova, Babak, & Moravkova,
2018). Land animals have been identified as carriers of Yersinia spp., spreading the bacteria
in the environment in their faeces (Novoslavskij et al., 2016). Of the strains identified in this
study, Y. intermedia have been isolated from water and fish, and Y. kristensenii has been
recovered from food, soil and fresh water sources (Whitman, 2015). Y. enterocolitica, a welldocumented strain of Yersinia which is a significant foodborne pathogen, was not identified
in this study (Le Guern, Martin, Savin, & Carniel, 2016). The potential pathogenicity of the
Yersinia spp. identified in this study, towards animals or humans is not fully understood since
they are less known and less researched, although they have previously been isolated from
patients suffering from acute diarrhoea and could possibly be opportunistic pathogens
(Shilpi, Sarita, Sachin, & Jugsharan, 2007; Stock & Wiedemann, 2003). However, the risk
appears low based on a previous finding that environmental strains of Y. kristensenii, (n =
154) and Y. intermedia (n = 122) were not pathogenic to humans (Le Guern et al., 2016).

Cefalotin and ampicillin: In this study, intermediate susceptibility to cefalotin was observed
in Y. kristensenii (n=1) and resistance to cefalotin and ampicillin was observed in Y.
intermedia (n=1). This finding is typical since Y. kristensenii, and Y. intermedia have
previously demonstrated resistance to cefalotin and ampicillin (Ahmedy, Vidon, Delmas, &
Lett, 1985; Freney et al., 1988). Resistance to beta-lactam antibiotics have been linked to
the production of beta-lactamases in Y. enterocolitica (Verbikova et al., 2018). Therefore, the
resistance observed in Y. kristensenii, and Y. intermedia, to ampicillin and cefalotin, may be
from the production of beta-lactamases (Shilpi et al., 2007). The Y. kristensenii, and Y.
intermedia were both isolated from the same crimson snapper (Lutjanus erythropterus)
labelled wild caught. There are differences between typical antibiotic susceptibility patterns
between Yersinia species (Stock & Wiedemann, 2003).

Tetracycline, sulfonamides and streptomycin: The Yersinia spp. in this study were
susceptible to the remaining antibiotics tested, including tetracycline and sulfonamides. This
is line with expectations for strains of this species isolated from food, which generally
demonstrate low levels of antibiotic resistance (Ahmedy et al., 1985). However, it was
expected that Y. intermedia would demonstrate resistance to streptomycin, which this study
did not find (Whitman, 2015).
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5.2.7 Pseudomonas species
Pseudomonas spp. are widely disseminated in the environment (Whitman, 2015). This study
isolated Pseudomonas alcaligenes from fish which is unsurprising since this strain has
previously been found in soil and water and has been implicated in the outbreak of infectious
disease in aquaculture species (Xu et al., 2015). Limited information is available detailing its
potential to cause disease in humans, however rare reports suggest it is an uncommon
human pathogen which can cause opportunistic infection in the eyes, heart or lungs
(Valenstein, Bardy, Cox, & Zwadyk, 1983).

The susceptibility data for P. alcaligenes obtained in this study must be read with caution.
There are incomplete susceptibility breakpoint guidelines for Pseudomonas spp. with the
antibiotics tested. Therefore, the antimicrobial susceptibility results for P. alcaligenes. were
inferred using interpretation criteria based on CLSI and EUCAST breakpoints for
Enterobacteriaceae (CLSI, 2018b; EUCAST, 2018a).

Cefalotin, ampicillin and cefalexin: This study found P. alcaligenes (n=1) was resistant to
cefalotin, ampicillin and cefalexin. This resistance is typical since Pseudomonas spp. are
intrinsically resistant to most beta-lactam antibiotics (Noor Uddin et al., 2013). This result is
similar to an Australian study which found Pseudomonas spp. (n = 4) isolated from farmed
fish were resistant to ampicillin, cefalexin and cefalotin (Akinbowale et al., 2006). Global
studies found similar results, resistance to ampicillin was observed in 99% of Pseudomonas
isolated from Vietnamese catfish (Nguyen et al., 2014) and resistance to cefalotin (75%) was
found in clinical P. alcaligenes isolates in the USA (Gilardi, 1971).

Nalidixic acid, trimethoprim, tetracycline and streptomycin: Our study did not detect
resistance to nalidixic acid, trimethoprim, tetracycline and streptomycin in the one P.
alcaligenes isolate. This result demonstrates less antibiotic resistance in comparison with
results from previous Australian studies conducted in 2006 and 2007 (Akinbowale et al.,
2006; Akinbowale et al., 2007). In 2006, Pseudomonas spp. (n = 4) isolated from Australian
farmed fish or water from crustacean rearing tanks were resistant to nalidixic acid (75%),
trimethoprim (50%) and tetracycline (25%) (Akinbowale et al., 2006). In 2007, Pseudomonas
spp. (n = 44) isolated from Australian farmed rainbow trout (Oncorhynchus mykiss) were
resistant to streptomycin (43.2%) and trimethoprim (95.5%) (Akinbowale et al., 2007). The
2007 study did not detect resistance to tetracycline, which is a similar result to this study
(Akinbowale et al., 2007). The two previous studies isolated bacteria from aquaculture
sources and it is possible that antibiotic resistance rates were higher due to exposure to
antibiotics (Akinbowale et al., 2006). In contrast, this study analysed Pseudomonas spp.
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isolated from Australian sourced Point Samson Rankin Cod (Epinephelus multinotatus)
which is a fish that is likely wild caught and is not a common aquaculture species (Froese &
Pauly, 2018).

5.2.8 Buttiauxella species.
Buttiauxella agrestis is ubiquitous in nature and has previously been isolated from water, soil
and aquatic organisms (Antonello et al., 2014). The clinical significance of B. agrestis is
limited and it has not been identified isolated in the hospital setting. There have been few
reports outlining the potential pathogenicity of B. agrestis to humans, for instance, one rare
case identified post caesarean surgical site infection due to B. agrestis which was believed
to be community acquired (Antonello et al., 2014; Whitman, 2015).

The B. agrestis (n=4) strains in the study were susceptible to the antibiotics tested, except
for cefalotin. One isolate demonstrated resistance to cefalotin and the remaining three (75%)
demonstrated intermediate susceptibility. Limited antimicrobial susceptibility data is available
on B. agrestis since it is an uncommon human pathogen, however our findings appear
consistent with available data. Cefalotin has previously been identified as being inactive
against B. agrestis, a finding agreed with by a previous study which found 100% of B.
agrestis isolates (n=13) were resistant to cefalotin (Freney et al., 1988; Whitman, 2015).
Similar to our results, high levels of susceptibility were previously found in B. agrestis to a
several antibiotics, including ampicillin and the combination of trimethoprim with
sulfamethoxazole (co-trimoxazole) (Stone, O'Hara, Williams, McGowan, & Tenover, 2007)

5.2.9 Pantoea species
Pantoea spp. are commonly found in the environment, on plants and soil, and have been
isolated from human and animal body fluids (Shubov, Jagannathan, & Chin-Hong, 2011).
Pantoea agglomerans, previously named Enterobacter agglomerans, has been isolated from
catfish effluent and diseased rainbow trout in previous antimicrobial susceptibility studies
(Chuah et al., 2016; Saticioglu et al., 2018). P. agglomerans can cause disease in plants,
animals and humans (Saticioglu et al., 2018). It is opportunistic, mainly causing infection in
human wounds following trauma to the skin caused by plant material (Cruz, Cazacu, & Allen,
2007). Nosocomial infection can occur in immunocompromised individuals or neonates
exposed to P. agglomerans, causing pneumonia, UTIs and bacteremia (Saticioglu et al.,
2018).
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This study found that P. agglomerans (n=1) were susceptible to eight antibiotics. This finding
is in contrast to the expectation that P. agglomerans strains are naturally resistant to
ampicillin and cefalotin (Whitman, 2015), although, P. agglomerans isolates from clinical
samples have demonstrated variability in susceptibility to ampicillin and cephalosporins,
including cefalotin (Cruz et al., 2007; Geere, 1977). Similar to this study’s result, P.
agglomerans isolated from rainbow trout in a previous study were susceptible to all nine
antibiotics tested, including sulfamethoxazole-trimethoprim, amoxicillin and tetracycline
(Saticioglu et al., 2018).

5.2.10 Pluralibacter species
Pluralibacter gergoviae, previously known as Enterobacter gergoviae, is generally found in
the environment, often in water (Whitman, 2015). There is limited information on the
pathogenicity of P. gergoviae. Previous studies indicate P. gergoviae is a rare human
pathogen which can cause nosocomial infections, it has been implicated in causing
bacteremia in neonates, lower respiratory tract infection, UTIs and sepsis (Emeka et al.,
2012; Stock & Wiedemann, 2002). There is limited information on the anticipated
susceptibility of P. gergoviae since it is of low clinical significance (Emeka et al., 2012; Stock
& Wiedemann, 2002). In this study, P. gergoviae was susceptible to all antibiotics tested.
This result is not surprising as susceptibility to a range of antibiotics, including ampicillin and
cefalotin, has been demonstrated previously in P. gergoviae (Freney et al., 1988; Stock &
Wiedemann, 2002).

5.2.11 Country of Origin
The country of origin may have an association with the presence of antibiotic resistance in
Acinetobacter isolated from fish samples as there was more resistance seen to nalidixic
acid, and streptomycin in the bacteria isolated from imported fish in comparison with
Australian fish. However, the numbers in this study are quite small and it is therefore difficult
to make confident inferences.

The country of origin did not correlate with resistance in the Acinetobacter spp. to cefalotin,
cefalexin and trimethoprim since the antibiotic resistance profile was similar for the
Australian and imported Acinetobacter isolates. However, the country of origin may be
responsible for the unexpected resistance in Acinetobacter to nalidixic acid (n = 1), ampicillin
(n = 2) and streptomycin (n = 2). It is possible this resistance was acquired from antibiotic
exposure since Acinetobacter spp. are likely to develop resistance in response to selective
environment pressure (Maravić et al., 2016). The majority of the unexpected resistance in
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the Acinetobacter spp. was observed in fish (n = 3) originating from Vietnam. One isolate
was obtained from an Australian fish sample.

Varied resistance to nalidixic acid, ampicillin and streptomycin was observed in
Acinetobacter spp. isolated from snakehead fish (Ophiocephalus striatus, n = 1) and catfish
(Pangasius hypophthalmus, n = 2) imported from Vietnam. Ampicillin resistance was
observed in one Acinetobacter isolate obtained from crimson snapper (Lutjanus
erythropterus) from Australia. It is likely the fish were farm raised since catfish and
snakehead fish are common aquaculture species in Vietnam and crimson snapper is a
farmed fish species in Australia (Cheng et al., 2018; Pham et al., 2015). It is highly likely that
the fish were exposed to antibiotics during aquaculture production. There have been
previous reports that nalidixic acid, ampicillin and streptomycin are used in Asian
aquaculture; furthermore, ampicillin is approved for use in Vietnamese aquaculture (Binh et
al., 2018; Done et al., 2015; Rico et al., 2012). Ampicillin is not permitted for use in
Australian aquaculture but is permitted for disease treatment in certain agricultural animals
(APVMA, 2014).

There was no evidence that the country of origin was associated with different antibiotic
resistance profiles in Serratia species tested. Resistance in Serratia spp. (n = 10) to
cefalotin, cefalexin and ampicillin was typical for this genus which is often resistant to betalactams (Mahlen, 2011).

The other eight genera isolated in this study contained isolates obtained from either only fish
of Australian origin or only from imported fish. Therefore, there is insufficient information to
determine whether the country of origin is connected with different levels of antibiotic
resistance in bacterial isolates.

5.2.12 Health Risk (Infection) within Australia
There are direct and indirect risks related to the presence of bacteria on seafood. The
consumer is at a direct risk of developing an infection through consumption or contact with
the pathogenic bacteria on food (Fletcher, 2015). The indirect risk is through the transfer of
antibiotic resistant genes to pathogenic bacteria (Mo et al., 2015).

Of the fifteen bacterial species identified in this study, A. hydrophilia is the single species
that is a well-described foodborne pathogen (Praveen Kumar et al., 2016). There is a risk to
the consumer that the bacteria will remain on the fish if it is not cooked adequately
(Novoslavskij et al., 2016). During processing, poor hygiene and inadequate food handling
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practices can result in the transmission of bacteria around the kitchen surfaces and
equipment (Stein, 2011). Consequently, bacteria can be transmitted to raw food products or
onto the consumer’s hands which poses a hazard to the consumer (Aitken et al., 2016).
Contact with pathogenic bacteria on seafood with wounds and open skin can also cause
human infection (Elbashir et al., 2018). A. hydrophila is an aquatic bacterium that is most
likely to cause wound infection in a person handling fish with open skin (Alderman &
Hastings, 1998). S. fonticola and S. maltophilia are also associated with rare communityacquired wound infections and could also be a potential risk to the consumer by this
pathway.

The remaining bacteria identified in our study are not likely to pose a significant threat to
human health via the contamination of fish products (Gillespie & Hawkey, 2006; Whitman,
2015); because the pathogenicity is not well documented or the clinical significance is limited
for these species (Buttiauxella spp., Yersinia spp., Pseudomonas spp., Pluralibacter spp.
and Pantoea spp). Furthermore, Acinetobacter spp., Stenotrophomonas spp. and Rhizobium
spp. are mainly opportunistic pathogens which cause nosocomial infections in the
immunocompromised. Acinetobacter and Rhizobium are the only genera analysed in our
study that may potentially have acquired antibiotic resistant genes compared to previous
reports. These bacteria are both generally responsible for nosocomial infections. Therefore,
the risk of an antibiotic resistant infection due to the consumption or handling of seafood is
low.

The indirect risk to human health is through the dissemination of antibiotic resistant genes
between bacteria by horizontal gene transfer (Capita & Alonso-Calleja, 2013). Antibiotic
resistant gene exchange can occur between environmental bacteria and human pathogens,
leading to infection which is difficult to treat with existing medicines (Finley et al., 2013). The
exchange of antibiotic resistant genes between bacteria can occur at any stage of seafood
production, including in the aquatic environment, processing and during storage.
Acinetobacter, one of the predominant bacteria genera identified in this study are highly
resistant to multiple antibiotics and there is a risk of them disseminating antibiotic resistant
mobile genetic elements to other bacteria in the aquatic environment (Maravić et al., 2016).
In our study, Acinetobacter spp. possibly acquired resistance to nalidixic acid, streptomycin
and ampicillin. Antibiotic resistance could potentially transfer to pathogens which cause
infections in humans, increasing the risk of antibiotic resistant infections.
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5.3 Clostridium difficile presence in Fish
C. difficile, a bacterium often found in human and animal faeces, is a human pathogen that
may cause infection when ingested (Warriner, Xu, Habash, Sultan, & Weese, 2017). It is
theorised that C. difficile could potentially cause foodborne infection and it has previously
been isolated from food (Lim et al., 2018). Antibiotic exposure is a significant risk factor for
C. difficile infection (Putsathit et al., 2015). Therefore, the use of antibiotics in integrated
agricultural and aquaculture farms may encourage the transmission of C. difficile infection.

C. difficile was not detected in all fish samples (n = 44) from this study. This finding is lower
than reported previously in other countries which have detected C. difficile in beef, chicken
and seafood (Warriner et al., 2017). Furthermore, a previous study detected C. difficile in
4.8% of seafood (n = 119) in Canada (Metcalf et al., 2011). A similar prevalence was
observed in a US study which detected C. difficile in 4.5% of shellfish and finfish samples (n
= 67) (Norman et al., 2014). In China, bacteria of the genera Clostridium have been detected
in water and sediment samples obtained from aquaculture, however, this study did not
identify the bacteria to species level and the presence C. difficile was not confirmed (Xiong
et al., 2015).

The prevalence of C. difficile in food has previously been attributed to contamination with
animal manure or raw sewage pollution (Lim et al., 2018; Norman et al., 2014). Therefore,
the result in this study suggests that the fish were potentially sourced from an environment
without faecal contamination. There was no difference between the result for the fish from
Australia and the imported fish despite differences in farming practices, such as integrated
farming of agricultural animals with aquaculture which is popular in Asian countries. The
Australian consumer does not appear to be at risk of C. difficile infection from the
consumption of seafood, irrespective of the product’s country of origin.
5.4 Bacterial Load
One third of the fish samples (n = 44) analysed did not demonstrate any bacterial growth on
MAC agar. This finding is in contrast with previous studies that isolated bacteria from all
analysed fish samples (Fuentes-Amaya, Munyard, Fernandez-Piquer, & Howieson, 2016;
Kulawik et al., 2016). The difference is likely attributed to our study design which was
selective for the growth of Gram negative bacteria. The bacterial load obtained is limited to
organisms that can grow on MAC and represents a portion of the total bacterial colonisation
of the fish samples. In comparison, previous studies calculated the total viable count (TVC)
of bacteria isolated from fish using less restrictive agar, such as plate count agar (Fuentes-
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Amaya et al., 2016; Kulawik et al., 2016). Therefore, our figures obtained are likely an
underestimate of the TVC.

The remaining two-thirds of fish samples demonstrated bacterial growth, ranging from 100 to
6.6 × 105 MCFU/g. There was no significant difference between the levels of bacteria
isolated from Australian and imported fish. All results were within the satisfactory
microbiological assessment reference limit for raw fish (< 106 CFU/g) (Health Protection
Agency, 2009). Due to the selective nature of our culture, the MCFU is an underestimate
and the total CFU results may have been close to, or over, the satisfactory limit. Raw fish
typically have high bacterial counts due to the presence of naturally occurring bacteria
(FSANZ, 2018b). Based on the estimated Gram negative MCFU/g results there is limited risk
to the consumer, particularly since the fish in this study are raw which must be cooked
before consumption (Committee on the Review of the Use of Scientific Criteria and
Performance Standards for Safe Food, 2003).

5.5 Study Limitations
This study focused on the isolation of Gram negative bacteria and there are several
limitations which reduced the range of bacterial species growth, including the use of
selective media, incubation time and incubation temperature. Therefore, the type of bacteria
grown from the fish samples was reduced in variety. Another limitation is the small number
of colonies which were assessed in preliminary tests and consequently, the small sample
size. This study was conducted in Perth in Western Australia which is a limited geographical
area for sample collection and may limit the generalisation of the findings to other regions in
Australia.
6.0 Summary and Recommendations
There were two components to this study, an analysis of antibiotic residues in seafood and
the presence of antibiotic resistant bacteria on fish. Firstly, a survey tested the concentration
of eight antibiotics in 253 seafood products originating in 22 countries, purchased throughout
WA. This study determined the concentration of eight antibiotics were below the LOR in
99.6% (n=252) of the seafood samples sold in Australia. Compliance with the maximum
allowable antibiotic limits stipulated in the ANZFSC and the Food Act 2008 (WA) were
observed in 99.6% of the seafood tested. One sample contravened the legislation with the
detection of erythromycin in seafood sticks originating from Thailand. However, the
concentration of erythromycin did not pose an immediate threat to human health, based on
guidelines provided by the Codex Alimentarius Commission.
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The high compliance in this study suggests that seafood sold in Australia is free from
antibiotic residue contamination, except for one sample imported from Thailand. Our result
suggests an increase in compliance compared to the AQIS survey conducted by the
Australian government in 2006 and 2007. Our result contrasts with global studies which have
found an increased occurrence of antibiotic residues contaminating seafood produced
throughout Asia. The difference is likely attributed to Australia’s strict border testing and food
safety legislation, in comparison to Asian countries. Asian farmers may have an increased
awareness of the legislative requirements to export seafood to Australia and comply to
protect their profits. It has been determined that there are different standards in Aquaculture
production in Asia depending on whether the product is intended for export or the domestic
market. Fish farmers are instructed to wait certain withdrawal periods after using antibiotics
to ensure that antibiotic residues are not present. Australian border tests do not assess food
for antibiotic resistant bacteria. Antibiotic resistance studies should be performed on aquatic
bacteria to assess the public health risk associated with antibiotic use in aquaculture more
precisely.

Secondly, our study analysed 44 pre-packaged fish samples originating in seven countries
and purchased in Perth, WA for the presence of antibiotic resistant Gram negative bacteria.
Thirty-five isolates comprising fifteen different environmental bacterial species from ten
different genera were identified by MALDI-TOF. Potential pathogens were identified which
may pose a direct risk to the consumer. A. hydrophilia is a possible foodborne pathogen and
wound infection could potentially occur in the kitchen from open skin contact with A.
hydrophilia, S. maltophilia or S. fonticola. There is an additional indirect risk to public health
with Acinetobacter spp. potentially spreading antibiotic resistant genes in the environment,
potentially to pathogenic species. The other isolates (Buttiauxella, Yersinia, Rhizobium,
Pseudomonas, Pantoea, Pluralibacter species) are rare human pathogens which generally
cause nosocomial infections and therefore are not likely to be a direct risk to the consumer
via fish consumption.

The disc diffusion test was conducted to test 35 bacteria for antibiotic resistance to eight
antibiotics. Most of the resistance found was intrinsic. However, potential acquired antibiotic
resistance was observed in four Acinetobacter species and a Rhizobium isolate which were
isolated from commonly farmed fish from Australia (n = 1), China (n = 1) and Vietnam (n =
3). It is possible the fish may have been exposed to antibiotics during the production cycle as
antibiotic misuse and overuse in the aquaculture industry have previously been linked to an
increase in antibiotic resistance in environmental bacterial strains. However, this result must
be read with caution since there are limited guidelines for these species. The influence of
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country of origin on the presence of antibiotic resistance in bacteria isolated from locally and
internationally sourced fish sold in Australia requires further investigation with a bigger
sample size.

Our results demonstrate that in Australia, the presence of antibiotic resistant bacteria on
seafood may currently pose a more significant threat to public health than antibiotic residue
contamination. There is a gap in knowledge regarding the extent of the public health impact
associated with the occurrence of antibiotic resistant bacteria in the food chain and antibiotic
resistant genes transferring to human pathogens from aquatic bacteria. A detailed
investigation is required to assess the extent of antibiotic resistance in Gram negative and
Gram positive bacteria to a broader range of antibiotics which are important for human
medicine. It is also suggested that future studies include analysis for antibiotic resistant
bacteria in seafood products which are eaten raw, such as sashimi or ceviche, since the risk
to the consumer is heightened without the cooking step to eliminate bacteria. Furthermore, it
is recommended that future studies focus predominantly on farmed fish products which
should be evaluated more regularly and with more rigour.

It is also recommended that the Australian government create new policy and allocate
funding for routine surveillance of antibiotic resistance in bacteria isolated from domestic and
imported food of animal origin, to monitor this potential risk to human public health. This
matter was raised as a recommended priority area of action in the Australian Government’s
National Antimicrobial Resistance Strategy (Department of Health & Department of
Agriculture, 2015). It is anticipated that action will be taken by 2019 to address this uncertain
risk, however, it is of concern that some recommendations outlined in JETCAR’s 1999 report
to mitigate the risk of antibiotic resistance have not yet been implemented by the Australian
government (APVMA, 2017).

In conclusion, our study found the risk of toxicity or allergy to the Australian consumer is low
from the consumption of seafood. Secondly, our results suggest that there is possible risk to
human health from the development of antibiotic resistance in bacteria on fish. Further
research is required to assess the public health risk to the consumer posed by the presence
of antibiotic resistant bacteria in the food chain.
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Cañada-Cañada, F., Muñoz de la Peña, A., & Espinosa-Mansilla, A. (2009). Analysis of
antibiotics in fish samples. Analytical and Bioanalytical Chemistry, 395(4), 987-1008.
doi:10.1007/s00216-009-2872-z
Capita, R., & Alonso-Calleja, C. (2013). Antibiotic-resistant bacteria: a challenge for the food
industry. Critical Reviews in Food Science and Nutrition, 53(1), 11-48. doi:10.1
080/10408398.2010.519837
Carlet, J. (2014). Antibiotic resistance: Protecting antibiotics - the declaration of the world
alliance against antibiotic resistance. Indian Journal of Critical Care Medicine, 18(10),
643-645. doi:10.4103/0972-5229.142171
Chen, C. Y., Hansen, K. S., & Hansen, L. K. (2008). Rhizobium radiobacter as an
opportunistic pathogen in central venous catheter-associated bloodstream infection:
case report and review. The Journal of Hospital Infection, 68(3), 203-207. doi:10.101
6/j.jhin.2007.11.021
Chen, H., Liu, S., Xu, X.-R., Liu, S.-S., Zhou, G.-J., Sun, K.-F., . . . Ying, G.-G. (2015).
Antibiotics in typical marine aquaculture farms surrounding Hailing Island, South
China: Occurrence, bioaccumulation and human dietary exposure. Marine Pollution
Bulletin, 90(1-2), 181-187. doi:10.1016/j.marpolbul.2014.10.053
Cheng, D., Ma, Z., Yang, Q., Hassan, M. M., & Qin, J. G. (2018). Skeletal ontogeny and
anomalies in larval and juvenile crimson snapper, lutjanus erythropterus bloch, 1790.
Pakistan Journal of Zoology, 50(3), 799-807. doi:10.17582/journal.pjz/2018.50.3.799.
807
Chitmanat, C., Lebel, P., Whangchai, N., Promya, J., & Lebel, L. (2016). Tilapia diseases
and management in river-based cage aquaculture in northern Thailand. Journal of
Applied Aquaculture, 28(1), 9-16. doi:10.1080/10454438.2015.1104950
Chuah, L.-O., Effarizah, M. E., Goni, A. M., & Rusul, G. (2016). Antibiotic application and
emergence of multiple antibiotic resistance (MAR) in global catfish aquaculture.
Current Environmental Health Reports, 3(2), 118-127. doi:10.1007/s40572-016-0091
2
Clark, N. M., & Chenoweth, C. E. (2003). Aeromonas infection of the hepatobiliary system:
report of 15 cases and review of the literature. Clinical Infectious Diseases, 37(4),
506-513. doi:1058-4838/2003/3704-0006$15.00
Clinical and Laboratory Standards Institute. (2010). Methods for Antimicrobial Dilution and
Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved
Guideline. (2nd ed.). Wayne, PA: Clinical and Laboratory Standards Institute.
Retrieved from https://clsi.org.
Clinical and Laboratory Standards Institute. (2018a). Breakpoints Eliminated from CLSI
document document M100 since 2010. Retrieved from https://clsi.org.
63

Clinical and Laboratory Standards Institute. (2018b). Performance Standards for
Antimicrobial Susceptibility Testing (M100) (28th Ed.). Wayne, PA: Clinical and
Laboratory Standards Institute.
Codex Alimentarius Commission. (2016). Codex Pesticides Residues in Food Online
Database: Glossary of Terms. Retrieved from http://www.fao.org/fao-whocodexalimentarius.
Codex Alimentarius Commission. (2017). Maximum Residue Limits (MRLs) and Risk
Management Recommendations (RMRs) for Residues of Veterinary Drugs in Foods.
(CAC/MRL 2-2017). Retrieved from http://www.fao.org/.
Collignon, P. (2015). Antibiotic resistance: are we all doomed? Internal Medicine Journal,
45(11), 1109-1115. doi:10.1111/imj.12902
Committee on the Review of the Use of Scientific Criteria and Performance Standards for
Safe Food. (2003). Scientific Criteria to Ensure Safe Food. Retrieved from
https://ebookcentral.proquest.com
Cooksey, R. C., Bannister, E. R., & Farrar, W. E. (1975). Antibiotic resistance patterns of
clinical isolates of Serratia marcescens. Antimicrobial Agents and Chemotherapy,
7(4), 396-399. Retrieved from http://aac.asm.org
Costin, S., & Ionut, S. (2017). ABIS online - Advanced Bacterial Identification Software, an
original tool for phenotypic bacterial identification. Retrieved from http://www.tgw1916
.net/
Cruz, A. T., Cazacu, A. C., & Allen, C. H. (2007). Pantoea agglomerans, a plant pathogen
causing human disease. Journal of Clinical Microbiology, 45(6), 1989-1992. doi:10.1
128/JCM.00632-07
Dalla-Costa, L. M., Coelho, J. M., Souza, H. A., Castro, M. E., Stier, C. J., Bragagnolo, K. L.,
. . . Woodford, N. (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii
producing the OXA-23 enzyme in Curitiba, Brazil. Journal of Clinical Microbiology,
41(7), 3403-3406. doi:10.1128/JCM.41.7.3403-3406.2003
Deng, W., Li, N., Zheng, H., & Lin, H. (2016). Occurrence and risk assessment of antibiotics
in river water in Hong Kong. Ecotoxicology and Environmental Safety, 125, 121-127.
doi:10.1016/j.ecoenv.2015.12.002
Department of Agriculture and Water Resources. (2015). Australia's seafood trade.
Canberra, ACT. Retrieved from http://www.agriculture.gov.au.
Department of Agriculture and Water Resources. (2016). Food inspection and compliance.
Retrieved from http://www.agriculture.gov.au.
Department of Agriculture and Water Resources. (2017a). National Residue Survey: 2016 –
17 Fish. Canberra, ACT. Retrieved from http://www.agriculture.gov.au/.
Department of Agriculture and Water Resources. (2017b). National Residue Survey:
Aquaculture Barrmundi residue testing annual datasets 2016 -17. Canberra, ACT.
Retrieved from http://www.agriculture.gov.au/.
Department of Fisheries. (2017). Recreational fishing identification guide (5th ed.). Perth,
WA: Department of Fisheries. Retrieved from http://www.fish.wa.gov.au/.
Department of Health, & Department of Agriculture. (2015). Responding to the threat of
antimicrobial resistance: Australia’s First National Antimicrobial Resistance Strategy
64

2015–2019. Canberra, ACT: Commonwealth of Australia. Retrieved from http://www.
agriculture.gov.au.
Done, H. Y., & Halden, R. U. (2015). Reconnaissance of 47 antibiotics and associated
microbial risks in seafood sold in the United States. Journal of Hazardous Materials,
282, 10-17. doi:10.1016/j.jhazmat.2014.08.075
Done, H. Y., Venkatesan, A. K., & Halden, R. U. (2015). Does the recent growth of
aquaculture create antibiotic resistance threats different from those associated with
land animal production in agriculture? The AAPS Journal, 17(3), 513-524.
doi:10.1208/s12248-015-9722-z
Dortet, L., Legrand, P., Soussy, C. J., & Cattoir, V. (2006). Bacterial identification, clinical
significance, and antimicrobial susceptibilities of Acinetobacter ursingii and
Acinetobacter schindleri, two frequently misidentified opportunistic pathogens.
Journal of Clinical Microbiology, 44(12), 4471-4478. doi:10.1128/JCM.01535-06
Economou, V., & Gousia, P. (2015). Agriculture and food animals as a source of
antimicrobial-resistant bacteria. Infection and Drug Resistance, 8, 49-61.
doi:10.2147/IDR.S55778
Elbashir, S., Parveen, S., Schwarz, J., Rippen, T., Jahncke, M., & DePaola, A. (2018).
Seafood pathogens and information on antimicrobial resistance: A review. Food
Microbiology, 70, 85-93. doi:10.1016/j.fm.2017.09.011
Emeka, B. K., Chinenye, N. K., George, O. A., Kelechi, E. O., Andrew, E. D., Adewuyi, M.
G., & Sylvester, U. E. (2012). Tension Pneumatocele due to Enterobacter gergoviae
Pneumonia: A Case Report. Case Reports in Medicine, 2012, 1-3. doi:10.1155/2012/
808630
European Commission. (2018). EU import conditions for seafood and other fishery products.
Retrieved from http://europa.eu/
European Committee on Antimicrobial Susceptibility Testing. (2012). Stenotrophomonas
maltophilia. Retrieved from http://www.eucast.org
European Committee on Antimicrobial Susceptibility Testing. (2017). EUCAST Disk Diffusion
Method for Antimicrobial Susceptibility Testing (Version 6.0). Retrieved from
http://www.eucast.org
European Committee on Antimicrobial Susceptibility Testing. (2018a). Breakpoint tables for
interpretation of MICs and zone diameters (Version 8.0). Retrieved from
http://www.eucast.org
European Committee on Antimicrobial Susceptibility Testing. (2018b). Routine and extended
internal quality control for MIC determination and disk diffusion as recommended by
EUCAST (Version 8.0). Retrieved from http://www.eucast.org
Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., & Dimopoulos, G. (2009). Communityacquired Stenotrophomonas maltophilia infections: a systematic review. European
Journal of Clinical Microbiology & Infectious Diseases, 28(7), 719-730. doi:10.1007/s
10096-009-0709-5
Farmery, A. K., Gardner, C., Green, B. S., Jennings, S., & Watson, R. A. (2015). Domestic
or imported? An assessment of carbon footprints and sustainability of seafood
consumed in Australia. Environmental Science and Policy, 54, 35-43. doi:10.1016/j.e
nvsci.2015.06.007
65

Finley, R. L., Collignon, P., Larsson, D. G. J., McEwen, S. A., Li, X.-Z., Gaze, W. H., . . .
Topp, E. (2013). The scourge of antibiotic resistance: the important role of the
environment. Clinical Infectious Diseases, 57(5), 704-710. doi:10.1093/cid/cit355
Fletcher, S. (2015). Understanding the contribution of environmental factors in the spread of
antimicrobial resistance. Environmental Health and Preventive Medicine, 20(4), 243252. doi:10.1007/s12199-015-0468-0
Food and Agriculture Organisation of the United Nations. (2016). The State of World
Fisheries and Aquaculture 2016: Contributing to food security and nutrition for all.
Rome, Italy: Food and Agriculture Organisation of the United Nations. Retrieved from
http://www.fao.org/
Food and Agriculture Organisation of the United Nations. (2018). National Aquaculture
Sector Overview: Indonesia. Retrieved from http://www.fao.org/fishery/countrysector/
naso_indonesia/en
Food Standards Australia New Zealand. (2016). Australia New Zealand Food Standards
Code. (Standard 1.4.2- Agvet Chemicals). Retrieved from http://www.foodstandards.
gov.au/
Food Standards Australia New Zealand. (2018a). Chemicals in food - maximum residue
limits. Retrieved from http://www.foodstandards.gov.au.
Food Standards Australia New Zealand. (2018b). Compendium of Microbiological Criteria for
Food. Kingston, ACT: Food Standards Australia New Zealand. Retrieved from
https://www.foodstandards.gov.au.
Forslund, K., Sunagawa, S., Kultima, J. R., Mende, D. R., Arumugam, M., Typas, A., & Bork,
P. (2013). Country-specific antibiotic use practices impact the human gut resistome.
Genome Research, 23(7), 1163-1169. doi:10.1101/gr.155465.113
Freney, J., Husson, M. O., Gavini, F., Madier, S., Martra, A., Izard, D., . . . Fleurette, J.
(1988). Susceptibilities to antibiotics and antiseptics of new species of the family
Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 32(6), 873-876.
Retrieved from https://aac.asm.org/
Froese, R., & Pauly, D. (2018). FishBase. World Wide Web electronic publication. Retrieved
from http://www.fishbase.org/
Fuentes-Amaya, L. F., Munyard, S., Fernandez-Piquer, J., & Howieson, J. (2016). Sensory,
Microbiological and Chemical Changes in Vacuum-Packaged Blue Spotted Emperor
(Lethrinus sp), Saddletail Snapper (Lutjanus malabaricus), Crimson Snapper
(Lutjanus erythropterus), Barramundi (Lates calcarifer) and Atlantic Salmon (Salmo
salar) Fillets Stored at 4°C. Food Science & Nutrition, 4(3), 479-489. doi:10.1002/fsn
3.309
Galbraith, A., Bullock, S., & Manias, E. (2004). Fundamentals of pharmacology (4th ed.).
Frenchs Forest, NSW: Pearson Education Australia.
Geere, I. W. (1977). Enterobacter agglomerans: the clinically important plant pathogen.
Canadian Medical Association Journal, 116(5), 517-519. Retrieved from http://www.c
maj.ca/
Gilardi, G. L. (1971). Antimicrobial susceptibility as a diagnostic aid in the identification of
nonfermenting Gram-Negative bacteria. Applied Microbiology, 22(5), 821-823.
Retrieved from https://onlinelibrary.wiley.com/journal/13652672
66

Gillespie, S. H., & Hawkey, P. M. (2006). Principles and Practice of Clinical Bacteriology
(2nd ed.). Chichester, UK: John Wiley & Sons.
Google. (2018). [Google Maps Data Western Australia]. Retrieved from
https://www.google.com/maps/place/Western+Australia
Gualerzi, C. O., Brandi, L., Fabbretti, A., & Pon, C. L. (2013). Antibiotics: targets,
mechanisms and resistance. Weinheim, Germany: Wiley-VCH.
Hanekamp, J. C., & Bast, A. (2015). Antibiotics exposure and health risks: Chloramphenicol.
Environmental Toxicology and Pharmacology, 39(1), 213-220. doi:10.1016/j.etap.201
4.11.016
Hardy Diagnostics. (1996). Oxistrips oxidase strips and oxisticks oxidase swabs. Santa
Maria, CA: Hardy Diagnostics.
He, Y., Jin, L., Sun, F., Hu, Q., & Chen, L. (2016). Antibiotic and heavy-metal resistance of
Vibrio parahaemolyticus isolated from fresh shrimps in Shanghai fish markets, China.
Environmental Science and Pollution Research International, 23(15), 15033-15040.
doi:10.1007/s11356-016-6614-4
Health Protection Agency. (2009). Guidelines for Assessing the Microbiological Safety of
Ready-to-Eat Foods Placed on the Market. London, UK: Public Health England
Retrieved from https://www.gov.uk/government/organisations/public-health-england.
Henriksson, P. J. G., Rico, A., Troell, M., Klinger, D. H., Buschmann, A. H., Saksida, S., . . .
Zhang, W. (2018). Unpacking factors influencing antimicrobial use in global
aquaculture and their implication for management: a review from a systems
perspective. Sustainability Science, 13(4), 1105-1120. doi:10.1007/s11625-0170511-8
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., . . .
Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial
resistance. The Lancet, 387(10014), 176-187. doi:10.1016/S0140-6736(15)00473-0
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8.0 Appendices
Appendix A
Microbact 12A Bacterial Identification Procedure

One isolated colony was picked from the TSA plate with a sterile loop, emulsified in a 2.5 mL
of sterile saline solution and then mixed to prepare a homogenous suspension. Each
Microbact well was inoculated with 100 µL of the bacterial suspension. Sterile Mineral Oil
(ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) was added to wells 1, 2 and 3.
The strips were incubated at 37°C for between 18 and 24 hours. After the incubation period
reagents were added to the appropriate wells of the Microbact test strip (Table 1A). The
wells were assessed visually for colour changes and the reaction was deemed as positive or
negative according to the manufacturer’s instructions. Results were recorded and the
Microbact wells were photographed to keep an electronic record (Figure 1A). To identify the
bacteria to genus level, the biochemical reactions were interpreted in accordance with the
Advanced Bacterial Identification Software (Costin & Ionut, 2017).

For each new Microbact 12A identification kit that was used, a quality control test was
conducted using E. coli ATCC 25922. One isolated colony was selected and tested as
described above. The identification information was compared to the expected parameters
for E. coli ATCC 25922 (Table 2A) (Thermo Fisher Scientific Inc., 2018).

Figure 1A. Microbact test results for fish sample 9A(3) (Buttiaxuella spp.) and 10A(1)
(Serratia spp.), following the incubation period and the addition of reagents.
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Table 1A. Microbact 12A Biochemical Identification Kit. Source: Thermo Fisher Scientific
Inc. (2018).
Well
Number

Reaction Principle

Mineral Oil
Added before
Incubation

Reagent(s)
Added after
Incubation

Time before
evaluation

1

Lysine Decarboxylase

Yes

N/A

Immediately

2

Ornthine Decarboxylase

Yes

N/A

Immediately

3

Hydrogen Sulfide Production

Yes

N/A

Immediately

4

Glucose fermentation

No

N/A

Immediately

5

Mannitol fermentation

No

N/A

Immediately

6

Xylose fermentation

No

N/A

Immediately

7

Hydrolysis of β-nitrophenylβ-d-galactosidase (ONPG)
by action of β-galactosidase

No

N/A

Immediately

7

Nitrates reduction (after
reading the ONPG reaction)

No

1 drop of Nitrate
A and 1 drop of
Nitrate B

2 minutes

8

Indole production from
tryptophan

No

2 drops of Indole

2 minutes

9

Urea hydrolysis

No

N/A

Immediately

10

Acetoin production (VoguesProskaür reaction)

No

1 drop of VPI and
1 drop of VPII

15 minutes

11

Citrate utilization

No

N/A

Immediately

12

Production of indolepyruvate
by deamination of
tryptophan

No

1 drop of TDA

Immediately
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Table 2A. Expected results on the Microbact 12A with E. coli ATCC 25922. Note. Source:
Thermo Fisher Scientific Inc. (2018).

Well Number

Reaction Principle

Expected Result

1

Lysine Decarboxylase

+

2

Ornthine Decarboxylase

+

3

Hydrogen Sulfide Production

-

4

Glucose fermentation

+

5

Mannitol fermentation

+

6

Xylose fermentation

+

7

Hydrolysis of β-nitrophenyl-β-d-galactosidase (ONPG) by
action of β-galactosidase

+

7

Nitrates reduction (after reading the ONPG reaction)

+

8

Indole production from tryptophan

+

9

Urea hydrolysis

-

10

Acetoin production (Vogues-Proskaür reaction)

-

11

Citrate utilization

-

12

Production of indolepyruvate by deamination of tryptophan

-
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Appendix B
Details of the Analysed Fish Products
Table 1B. Details of the 44 analysed fish products.

ID

Fish Label

Fish Scientific

Wild or

Country of

MALDI-TOF

MALDI-TOF

No.

Name

name

farmed*

Origin

Bacterial

Score Value

MCFU/g

Identification

1A

2A

3A

4A

Blue spot

Lethrinus

emperor

punctulatus

Crimson

Lutjanus

Snapper

erythropterus

Sweetlips

Diagramma

Bream

labiosum

Lake argyle

Neoarius midgleyi

2.597

6 X 10^ 3

2.342

9 X 10^ 2

N/A

0

2.09

1.02 X 10^ 5

Aeromonas
salmonicida

2.619

6.6 X 10^ 5

Aeromonas
hydrophila

2.457

6.6 X 10^ 5

N/A

0

2.423

2 X 10^ 2

2.05

4 X 10^ 1

2.444

4 X 10^ 1

2.099

3.6 X 10^ 4

2.334

6.7 X 10^ 3

Wild

Australia

Serratia fonticola

N/A

Australia

Acinetobacter
haemolyticus

N/A

Australia

N/A

N/A

Australia

Buttiauxella agrestis

silver
cobbler fillet
N/A
5A

Blue Spot

Lethrinus

Emperor

punctulatus

Blue Spot

Lethrinus

Emperor

punctulatus

Saddletail

Lutjanus

Snapper

malabaricus

Kingfish

Seriola lalandi

N/A
5A

6A

7A

Australia

Australia

N/A

Australia

N/A

N/A

Australia

Serratia fonticola

Fillet
N/A
8A

Point

Epinephelus

Samson

multinotatus

Australia

Pseudomonas
alcaligenes

Rankin Cod
N/A
8A

Point

Epinephelus

Samson

multinotatus

Australia

Serratia liquefaciens

Rankin Cod
N/A
9A

Painted

Diagramma

Sweetlip

labiosum

Sea Bream

Gymnocranius

Filllets

grandoculis

N/A
10A

Australia

Australia
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Buttiauxella agrestis

Pantoea
agglomerans

N/A
10A

Sea Bream

Gymnocranius

Filllets

grandoculis

Threadfin

Nemipterus

Pinky

furcosus

N/A
11A

Australia

Australia

Serratia liquefaciens
2.369

6.7 X 10^ 3

2.178

6.5 X 10^ 4

2.465

6.5 X 10^ 4

2.202

5.5 X 10^ 4

2.424

5.5 X 10^ 4

2.574

2.4 X 10^ 4

2.545

7 X 10^ 2

2.552

7 X 10^ 2

N/A

0

2.508

1 X 10^ 2

2.404

2 X 10^ 2

Buttiauxella agrestis

Bream
N/A
11A

Threadfin

Nemipterus

Pinky

furcosus

Australia

Serratia liquefaciens

Bream
N/A
12A

Saddletail

Lutjanus

Snapper

malabaricus
N/A

12A

13A

Saddletail

Lutjanus

Snapper

malabaricus

Moses

Lutjanus russellii

N/A

Australia

Australia

Australia

Snapper

Buttiauxella agrestis

Serratia liquefaciens

Aeromonas
hydrophila

Fillet
Wild
14A

Crimson

Lutjanus

Snapper

erythropterus

Crimson

Lutjanus

Snapper

erythropterus

Perch Pearl

Glaucosoma

Wild
14A

15A

Australia

Australia

Yersinia kristensenii

Yersinia intermedia

Wild

Australia

N/A

Wild

Australia

Serratia liquefaciens

buergeri
16A

Trevally

Pseudocaranx
georgianus
N/A

17A

Mandurah

Australia

Serratia fonticola

Mugil cephalus

Mullet Fillets
18A

Coral Trout

Plectropomus

N/A

Australia

N/A

N/A

0

N/A

Australia

N/A

N/A

0

N/A

Australia

Acinetobacter
haemolyticus

2.421

5 X 10^ 2

Acinetobacter
haemolyticus

2.451

7 X 10^ 2

Acinetobacter
haemolyticus

2.433

6 X 10^ 2

leopardus
19A

Red

Lutjanus sebae

Emperor
20A

Spangled

Lethrinus

Emperor

nebulosus

Goldband

Pristipomoides

Snapper

multidens

Basa

Pangasius

N/A
21A

N/A
1B

Australia

Vietnam

hypophthalmus
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2B

Emperor

Lethrinus sp.

Wild

Vietnam

N/A

N/A

1.2 X 10^ 3

N/A

Vietnam

Acinetobacter
haemolyticus

2.399

1.3 X 10^ 3

Fillets
3B

Basa

Pangasius
hypophthalmus

4B

5B
6B

Threadfin

Nemipterus

Bream

japonicus

Grouper

Epinephelussp.

Snakehead

Ophiocephalus

fish cutlets

striatus

Snakehead

Ophiocephalus

fish cutlets

striatus

Basa fillets

Pangasius

Wild

India

N/A

N/A

0

Wild

Indonesia

N/A

N/A

2.6 X 10^ 3

N/A

Vietnam

Acinetobacter
ursingii

2.316

7.1 X 10^ 3

Pluralibacter
gergoviae

2.403

7.1 X 10^ 3

Acinetobacter
haemolyticus

2.374

4.3 X 10^ 3

Acinetobacter
haemolyticus

2.444

1 X 10^ 3

N/A
6B

N/A
7B

Vietnam

Vietnam

hypophthalmus
N/A
8B

Basa White

Pangasius

Catfish

hypophthalmus

Alaska

Theragra

Pollack

chalcogramma

10B

Monkfish

11B

9B

12B

Vietnam

N/A

Korea

N/A

N/A

0

Lophius litulon

Wild

China

N/A

N/A

0

Smallscale

Cynoglossus

N/A

Vietnam

N/A

N/A

0

Tonguesole

Microlepis
Farmed

Vietnam

Serratia fonticola

Basa

Pangasius

2.483

1 X 10^ 2

2.446

1 X 10^ 2

hypophthalmus
Wild
13B

Hoki

New
Zealand

Serratia liquefaciens

Wild

China

N/A

N/A

3 X 10^ 2

Farmed

Vietnam

Acinetobacter
haemolyticus

2.362

1.7 X 10^ 3

Macruronus
novaezelandiae

14B

Hoki

Macruronus
novaezelandiae

15B

Basa

Pangasius
hypophthalmus

16B

Basa

Pangasius

N/A

Vietnam

N/A

N/A

0

Farmed

Vietnam

N/A

N/A

0

hypophthalmus
17B

Basa steak

Pangasius
hypophthalmus
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N/A
18B

19B

Grass Carp

Ctenopharyngodo

Cutlet

n idella

Ribbon Fish

Trichiurus

China

Rhizobium
radiobacter

2.256

1 X 10^ 2

N/A

Vietnam

N/A

N/A

0

N/A

Vietnam

Stenotrophomonas
maltophilia

2.3

1 X 10^ 2

Stenotrophomonas
maltophilia

2.3

4 X 10^ 2

N/A

0

2.464

1 X 10^ 3

Lepturus
20B

Basa cutlets

Pangasius
hypophthalmus
N/A

21B

Sweetlips

Lutjanus

Snapper

lemniscatus

Indonesia

Fillets
22B

Red Spot

Lethrinus lentjan

N/A

Indonesia

N/A

N/A

Indonesia

Acinetobacter junii

Emperor
23B

Goldband

Pristipomoides

Snapper

multidens

* N/A = inadequate labelling information
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Appendix C
Disc Diffusion Results
Table 1C. Zone diameter results from the disc diffusion test. Zone diameter interpretation
determined by EUCAST or CLSI and coloured by susceptibility result (green = susceptible,
yellow = intermediate, red = resistant).

Bacterial Species

ID no.

Zone Diameter (nearest whole mm)
TE*

CEF*

AMP*

CXN*

NA*

S*

TMP*

SUL*

Aeromonas

5A (2)

30

0

0

20

33

14

15

34

Aeromonas

5A (3)

30

0

0

17

34

14

22

36

Aeromonas

13A (3)

30

22

0

20

35

17

26

34

Buttiauxella

4A (1)

27

16

22

22

27

19

30

38

Buttiauxella

9A (3)

27

14

19

20

27

19

32

32

Buttiauxella

11A (2)

27

15

22

20

27

19

34

38

Buttiauxella

12A (2)

28

15

22

19

28

19

34

38

Pantoea

10A (2)

30

25

25

24

35

28

40

40

Pluralibacter

6B (4)

24

21

23

25

21

22

22

36

Serratia

1A (2)

28

0

11

N/A

33

19

34

36

Serratia

7A (2)

26

0

10

12

31

21

28

34

Serratia

8A (3)

20

0

17

11

30

22

23

32

Serratia

10A (1)

22

0

20

14

33

23

25

30

Serratia

11A (1)

21

12

19

21

31

22

25

34

Serratia

12A (3)

22

10

22

15

32

20

24

31

Serratia

16A (1)

25

0

14

10

33

22

28

36

Serratia

17A (2)

27

0

0

13

31

21

28

32

Serratia

12B (1)

29

0

18

20

36

23

32

30
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Serratia

13B (1)

21

0

20

13

32

22

26

30

Yersinia

14A (1)

28

0

12

22

32

30

24

38

Yersinia

14A (2)

29

17

23

21

34

21

28

34

Acinetobacter

2A (2)

25

0

11

0

25

23

0

34

Acinetobacter

20A (2)

22

0

19

9

24

19

10

38

Acinetobacter

21A (1)

22

0

18

9

23

18

10

36

Acinetobacter

1B (1)

18

8

17

N/A

19

21

0

29

Acinetobacter

3B (2)

19

0

0

0

28

0

10

44

Acinetobacter

6B (3)

27

0

22

14

11

26

13

41

Acinetobacter

7B (2)

20

12

21

13

23

9

14

32

Acinetobacter

8B (1)

20

8

18

10

23

18

0

34

Acinetobacter

15B (1)

28

0

15

8

27

20

12

32

Acinetobacter

23B (2)

23

14

25

18

26

24

12

39

Pseudomonas

8A (1)

28

0

9

0

24

19

20

50

Rhizobium

18B (1)

37

0

12

18

22

0

0

40

Stenotrophomonas

20B (1)

26

0

0

0

28

24

0

44

Stenotrophomonas

21B (4)

32

0

19

0

28

10

0

46

* TE = tetracyline, CEF = cefalotin, AMP = ampicillin, CXN = cefalexin, NA = nalidixic acid, S
= streptomycin, TMP = trimethoprim, SUL = sulfonamides.
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Appendix D
Quality Control Results for Disc Diffusion

Figure 1D. The diameter of E. coli ATCC 25922 resistance zones with the eight antibiotics
using the disc diffusion test conducted over 8 weeks. The upper and lower target range are
indicated with the black dashed lines. There is no provided range for E. coli ATCC 25922
with sulfonamides.
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